molecular formula C17H17ClO6 B1672149 Griseofulvin CAS No. 126-07-8

Griseofulvin

Cat. No.: B1672149
CAS No.: 126-07-8
M. Wt: 352.8 g/mol
InChI Key: DDUHZTYCFQRHIY-RBHXEPJQSA-N
Attention: For research use only. Not for human or veterinary use.
In Stock
  • Click on QUICK INQUIRY to receive a quote from our team of experts.
  • With the quality product at a COMPETITIVE price, you can focus more on your research.

Description

Historical Context of Griseofulvin Discovery and Initial Applications

The journey of this compound began in the mid-20th century with its isolation from fungal cultures.

This compound was first discovered and isolated from Penicillium griseofulvum by Oxford et al. in 1939. nih.govfrontiersin.orgdtu.dktaylorandfrancis.comtaylorandfrancis.com This soil fungus served as the initial source of the compound. wikipedia.org Beyond Penicillium griseofulvum, this compound has also been isolated from other species within the Penicillium genus, including Penicillium lanosocoeruleum and Penicillium aethiopicum. nih.govnih.gov Furthermore, its production has been observed in other genera of ascomycetes, such as Xylaria flabelliformis, Abieticola koreana, and Stachybotrys levispora. nih.govfrontiersin.org Fungal endophytes like Xylaria are known to produce this compound as an antifungal agent against plant pathogenic fungi. nih.govnih.gov

Initially, this compound was considered an antibiotic. frontiersin.org Early studies reported its in vitro antifungal effects and systemic antifungal activity in plants. dtu.dk this compound was first used to treat fungal diseases in plants before its application in animal and human mycoses in 1958. taylorandfrancis.comtaylorandfrancis.com Its effectiveness against ringworm infections caused by Microsporum canis and Trichophyton mentagrophytes in guinea pigs when administered orally was noted. dtu.dk This led to its development as an antifungal drug for treating dermatophytosis in humans. dtu.dk this compound was approved by the Food and Drug Administration (FDA) in 1959 and has since been widely used for treating dermatophyte infections in humans and animals. nih.gov It is effective against dermatophytes that cause tinea infections. taylorandfrancis.com

Isolation from Penicillium griseofulvum and other Ascomycetes

Current and Evolving Landscape of this compound Research

While this compound has established therapeutic roles, ongoing research is exploring its potential beyond traditional antifungal applications.

This compound remains a relevant antifungal agent, particularly for dermatophyte infections. nih.gov It is used orally for dermatophytosis, especially in cases where topical treatments are ineffective. wikipedia.org this compound is considered effective against Microsporum species, a primary cause of tinea capitis in many regions. nih.govtandfonline.com Its mechanism of action involves interfering with fungal mitosis by binding to tubulin, disrupting the mitotic spindle structure and inhibiting cell division. taylorandfrancis.comwikipedia.orgmims.com It also binds to keratin in keratin precursor cells, making them resistant to fungal infections. wikipedia.org

In recent decades, there has been increasing interest in the multifunctional applications of this compound. nih.gov Research has shown that this compound can disrupt mitosis and cell division in human cancer cells and inhibit hepatitis C virus replication. nih.govresearchgate.net It has demonstrated inhibitory effects on cancer cell division and may induce cell death through interaction with the mitotic spindle microtubule. nih.govwikipedia.orgmdpi.com Studies have shown that this compound inhibits the proliferation of various tumor cells by affecting spindle microtubules in mitosis, including lung, colorectal, breast, cervical, and liver cancer cells. frontiersin.org

Furthermore, this compound has shown potential in treating non-fungal inflammatory skin diseases like lichen planus and chronic purpuric dermatosis, suggesting possible anti-inflammatory and immunomodulatory effects. nih.gov It has also been explored for its potential to enhance ACE2 function, contribute to vascular vasodilation, and improve capillary blood flow. nih.govresearchgate.net Molecular docking analysis has indicated that this compound and its derivatives have binding potential with SARS-CoV-2 main protease, RNA-dependent RNA polymerase (RdRp), and spike protein receptor-binding domain (RBD), suggesting potential inhibitory effects on SARS-CoV-2 entry and viral replication. nih.govresearchgate.net These findings highlight the repurposing potential of this compound in developing new therapeutic interventions. nih.govresearchgate.net Computational studies are also investigating this compound and its derivatives for potential antibacterial activity, with some derivatives showing promising binding affinities to bacterial targets like FtsZ protein. researchgate.netresearchgate.netmdpi.com

While the outline did not provide specific numerical data points suitable for a traditional data table, the detailed research findings discussed above represent the core content for this section.

Biosynthesis and Production of this compound

This compound, a spirocyclic polyketide, is a natural antifungal compound primarily produced by species of the Penicillium genus, notably Penicillium griseofulvum and Penicillium aethiopicum. nih.govnih.govwikipedia.org Its biosynthesis is a complex process orchestrated by a dedicated gene cluster. nih.govnih.govnih.govmdpi.comresearchgate.netoup.com

Fungal Biosynthetic Pathway Elucidation

The elucidation of the this compound biosynthetic pathway has been a subject of research for many years, evolving from early isotopic labeling studies to modern genomic and biochemical analyses. nih.govrsc.orgrsc.org Initial studies using [1-14C]acetic acid in the 1950s suggested that the core structure was derived from acetate units. nih.govrsc.orgrsc.org Later 13C NMR studies clarified that the pathway involves a starter unit derived from acetyl-CoA and extender units from malonyl-CoA. nih.govrsc.org The complete assignment of the enzymatic steps was significantly advanced by comprehensive single-gene knockout investigations and in vitro reconstitution experiments. dtu.dknih.gov

Identification of the gsf Gene Cluster in Penicillium aethiopicum and Penicillium griseofulvum

The key to understanding this compound biosynthesis at the molecular level was the identification of the responsible gene cluster, known as the gsf cluster. nih.govnih.govnih.govmdpi.comresearchgate.netoup.com This cluster was first putatively identified in Penicillium aethiopicum through shotgun sequencing and bioinformatic mining in 2010. nih.govnih.govmdpi.comresearchgate.net Comparative genomics with Penicillium chrysogenum, a closely related species that does not produce this compound, was instrumental in this discovery. dtu.dk The gsf cluster in P. aethiopicum was found to contain 13 putative genes, designated gsfA through gsfK, along with regulatory genes gsfR1 and gsfR2. nih.govmdpi.comoup.comresearchgate.net Gene deletion studies confirmed the association between the gsf cluster and this compound biosynthesis. researchgate.netoup.comnih.gov While the gsf cluster has also been identified in P. griseofulvum, comparative genomic studies have shown some variations in gene content between different Penicillium species, with a core set of seven genes (gsfA-gsfF, gsfI) being largely conserved and considered essential for this compound production. nih.govnih.govoup.com

Enzymatic Steps and Intermediates in Polyketide Synthesis

The biosynthesis of this compound proceeds through a series of enzymatic steps, starting with the assembly of a polyketide backbone and involving several tailoring modifications. nih.govmdpi.comresearchgate.net

The initial step in this compound biosynthesis is catalyzed by GsfA, a nonreducing polyketide synthase (NR-PKS). nih.govnih.govmdpi.comresearchgate.netoup.comdtu.dkresearchgate.net GsfA is responsible for combining one molecule of acetyl-CoA as a starter unit with six molecules of malonyl-CoA as extender units. nih.govnih.govmdpi.comoup.comdtu.dkresearchgate.net This process generates a heptaketide backbone. nih.govnih.govmdpi.comoup.comresearchgate.net GsfA contains several functional domains typical of NR-PKSs, including starter unit ACP transacylase (SAT), ketosynthase (KS), malonyl-CoA-ACP transacylase (AT), product template (PT), and an acyl carrier protein (ACP). nih.govmdpi.comresearchgate.net The PT domain is thought to mediate the cyclization of the aromatic rings to form a benzophenone intermediate, specifically benzophenone 5a. nih.govmdpi.comresearchgate.netoup.com While GsfA can also produce norlichexanthone as a shunt product via spontaneous dehydration of the benzophenone, the methylated benzophenone is the true precursor for this compound. researchgate.netnih.govuniprot.org

Following the formation of the benzophenone intermediate, O-methylation of the phenol groups occurs, catalyzed by O-methyltransferases (MTs). nih.govnih.govmdpi.comresearchgate.netoup.comdtu.dknih.govresearchgate.net Specifically, GsfB and GsfC are identified as the O-methyltransferases involved in tailoring the nascent GsfA product. nih.govnih.govmdpi.comresearchgate.netoup.comnih.govresearchgate.netmybiosource.com Studies involving gene deletions and in vitro assays have confirmed their roles and regioselectivity. nih.gov GsfB is responsible for methylation at the 3-OH position, while GsfC methylates the 9-OH position of benzophenone 5a, leading to the formation of griseophenone C. nih.govnih.govmdpi.comoup.comnih.govresearchgate.netuniprot.org This methylation step is crucial as it is thought to hinder xanthone formation and keep the pathway directed towards this compound. nih.gov

A key step in the biosynthesis of this compound is the introduction of a chlorine atom, which is catalyzed by a halogenase enzyme, GsfI. nih.govmdpi.comresearchgate.netoup.comdtu.dknih.govresearchgate.netuniprot.orgebi.ac.ukf1000research.com GsfI is a flavin-dependent halogenase responsible for the regio-specific chlorination of griseophenone C. uniprot.orgebi.ac.uk This chlorination occurs at the C13 position, resulting in the formation of griseophenone B. wikipedia.orgnih.govmdpi.comoup.comresearchgate.netuniprot.orgoup.com Gene deletion of gsfI has been shown to disrupt this compound production and lead to the accumulation of dechlorothis compound, confirming its essential role in the pathway. nih.govnih.govresearchgate.netoup.comnih.govf1000research.com

The formation of the characteristic spirocyclic grisan core of this compound involves a phenol oxidative coupling reaction catalyzed by the cytochrome P450 enzyme, GsfF. nih.govmdpi.comresearchgate.netoup.comdtu.dknih.govresearchgate.netnih.gov GsfF mediates the oxidative cyclization of griseophenone B, leading to the formation of desmethyl-dehydrothis compound A, which contains the spirocyclic structure. uniprot.orgnih.gov This enzymatic step is critical for establishing the unique B ring structure of this compound. dtu.dk Computational and experimental studies suggest that GsfF likely performs this oxidative coupling through a double phenolic O-H abstraction mechanism. nih.gov

EnzymeGeneCatalyzed StepSubstrate(s)Product(s)
GsfAgsfAHeptaketide backbone formation & cyclizationAcetyl-CoA, Malonyl-CoABenzophenone 5a
GsfBgsfBO-methylation (3-OH)Benzophenone 5aGriseophenone D
GsfCgsfCO-methylation (9-OH)Benzophenone 5a or Griseophenone DGriseophenone C
GsfIgsfIChlorination (C13)Griseophenone CGriseophenone B
GsfFgsfFPhenol oxidative coupling (Grisan core formation)Griseophenone BDesmethyl-dehydrothis compound A

Properties

IUPAC Name

(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI

InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI Key

DDUHZTYCFQRHIY-RBHXEPJQSA-N
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Canonical SMILES

CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Isomeric SMILES

C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Molecular Formula

C17H17ClO6
Record name GRISEOFULVIN
Source CAMEO Chemicals
URL https://cameochemicals.noaa.gov/chemical/20442
Description CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.
Explanation CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

DSSTOX Substance ID

DTXSID8020674
Record name Griseofulvin
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID8020674
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.

Molecular Weight

352.8 g/mol
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Physical Description

Griseofulvin appears as white to pale cream-colored crystalline powder. Odorless or almost odorless. Tasteless. Sublimes without decomposition at 410 °F. (NTP, 1992), Solid
Record name GRISEOFULVIN
Source CAMEO Chemicals
URL https://cameochemicals.noaa.gov/chemical/20442
Description CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.
Explanation CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.
Record name Griseofulvin
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014544
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Solubility

less than 1 mg/mL at 70 °F (NTP, 1992), SOL IN N,N-DIMETHYLFORMAMIDE @ 25 °C: 12-14 G/100 ML; SLIGHTLY SOL IN ETHANOL, CHLOROFORM, METHANOL, ACETIC ACID, ACETONE, BENZENE, & ETHYL ACETATE; PRACTICALLY INSOL IN WATER & PETROLEUM ETHER, 5.04e-02 g/L
Record name GRISEOFULVIN
Source CAMEO Chemicals
URL https://cameochemicals.noaa.gov/chemical/20442
Description CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.
Explanation CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.
Record name Griseofulvin
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00400
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name GRISEOFULVIN
Source Hazardous Substances Data Bank (HSDB)
URL https://pubchem.ncbi.nlm.nih.gov/source/hsdb/1722
Description The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.
Record name Griseofulvin
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014544
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Color/Form

STOUT OCTAHEDRA OR RHOMBS FROM BENZENE, WHITE TO CREAMY POWDER, COLORLESS CRYSTALLINE SOLID

CAS No.

126-07-8, 2884-22-2
Record name GRISEOFULVIN
Source CAMEO Chemicals
URL https://cameochemicals.noaa.gov/chemical/20442
Description CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.
Explanation CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.
Record name Griseofulvin
Source CAS Common Chemistry
URL https://commonchemistry.cas.org/detail?cas_rn=126-07-8
Description CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.
Explanation The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.
Record name rel-(1′R,6′S)-7-Chloro-2′,4,6-trimethoxy-6′-methylspiro[benzofuran-2(3H),1′-[2]cyclohexene]-3,4′-dione
Source CAS Common Chemistry
URL https://commonchemistry.cas.org/detail?cas_rn=2884-22-2
Description CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.
Explanation The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.
Record name Griseofulvin [USP:INN:BAN:JAN]
Source ChemIDplus
URL https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000126078
Description ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.
Record name Griseofulvin
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00400
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name griseofulvin
Source DTP/NCI
URL https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=755822
Description The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.
Explanation Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.
Record name Griseofulvin
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID8020674
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.
Record name Griseofulvin
Source European Chemicals Agency (ECHA)
URL https://echa.europa.eu/substance-information/-/substanceinfo/100.004.335
Description The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.
Explanation Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
Record name GRISEOFULVIN
Source FDA Global Substance Registration System (GSRS)
URL https://gsrs.ncats.nih.gov/ginas/app/beta/substances/32HRV3E3D5
Description The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.
Explanation Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.
Record name GRISEOFULVIN
Source Hazardous Substances Data Bank (HSDB)
URL https://pubchem.ncbi.nlm.nih.gov/source/hsdb/1722
Description The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.
Record name Griseofulvin
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014544
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Melting Point

428 °F (NTP, 1992), 220 °C
Record name GRISEOFULVIN
Source CAMEO Chemicals
URL https://cameochemicals.noaa.gov/chemical/20442
Description CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.
Explanation CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.
Record name Griseofulvin
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00400
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name GRISEOFULVIN
Source Hazardous Substances Data Bank (HSDB)
URL https://pubchem.ncbi.nlm.nih.gov/source/hsdb/1722
Description The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.
Record name Griseofulvin
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014544
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Biosynthesis and Production of Griseofulvin

Fungal Biosynthetic Pathway Elucidation

Halogenase (GsfI) in Chlorination

Genetic Regulation of Griseofulvin Biosynthesis

The biosynthesis of this compound is subject to genetic regulation, involving transcriptional regulators and signaling pathways. ontosight.ai Within the gsf gene cluster, two putative transcription factors, gsfR1 and gsfR2, have been identified, although their precise functions have been a subject of investigation. nih.govnih.govmdpi.com Studies involving gene deletions have provided insights into their roles. For instance, deletion of the gsfR1 gene in P. griseofulvum has been shown to increase this compound biosynthesis by enhancing the expression of the gsfA gene under certain conditions, suggesting gsfR1 can act as a negative regulator. nih.govresearchgate.net However, under different culture conditions, such as high concentrations of nitrogen and complex sugars or media supplemented with peptone, gsfR1 appears to positively regulate this compound biosynthesis, indicating its response can vary depending on external stimuli, particularly the availability of carbon and nitrogen. nih.govresearchgate.net The gsfR2 gene, in contrast, may be involved in different metabolic pathways. nih.govmdpi.com The promoter region of gsfR1 suggests regulation by global regulators responsive to environmental cues like carbon and nitrogen availability. nih.govresearchgate.net

Strain Development and Optimization for Enhanced Production

Enhancing this compound production often involves strategies focused on strain development and optimizing fermentation conditions. ontosight.aigoogle.comjmb.or.kr

Genetic engineering approaches can be employed to improve the yield and productivity of desired metabolites like this compound in microorganisms. mdpi.com This can involve introducing or overexpressing genes related to the biosynthesis pathway or modifying competing pathways. mdpi.com While the provided text does not detail specific genetic engineering techniques applied to this compound-producing fungi, the concept of using such methods to enhance production is mentioned in the context of optimizing microbial cell factories for valuable compounds. mdpi.com Mutation and selection have historically been used to improve the productivity of this compound-producing organisms, with methods described in patent literature. google.com For example, a mutant strain of Penicillium griseofulvum (FH1816) obtained through UV and lithium chloride mutagenesis of an original strain (F3215) showed significantly improved this compound titers, with some mutant strains exhibiting a 150-500% increase and others over 500% compared to the original strain. google.com

Environmental and nutritional factors significantly influence this compound biosynthesis. nih.govontosight.ainih.govmdpi.com Organic compounds are critical environmental components affecting production. nih.govmdpi.com Rich media containing glucose, acetate, and succinate can increase this compound yield. nih.govmdpi.com Nitrogen concentration also plays a crucial role; concentrations below 0.04 g% or above 0.4 g% may inhibit biosynthesis. nih.govmdpi.com The cellular energy status, indicated by the ATP/ADP ratio, is another significant parameter regulating this compound synthesis; higher energy levels correlate with increased production. nih.gov pH is also an important factor, with the highest yields observed in a pH range of 5.5 to 6. mdpi.com Secondary metabolites like this compound are often synthesized during the stationary growth phase, potentially providing a competitive advantage against other fungal species. nih.govmdpi.com

Data on the influence of specific nutrients on this compound production by different Penicillium griseofulvum strains have been investigated. Using a Plackett-Burman experimental design, studies identified key medium constituents influencing production. For Penicillium griseofulvum MTCC 1898, sucrose, K2HPO4, NaNO3, and FeSO4·7H2O significantly impacted this compound production. jmb.or.kr For Penicillium griseofulvum MTCC 2004, lactose, glucose, and MnSO4·H2O were found to be significant factors. jmb.or.kr Optimization studies using central composite design have determined optimal concentrations for these nutrients to enhance production. jmb.or.kr

Genetic Engineering Approaches in Producer Fungi

Analogues and Derivatives of this compound from Fungal Sources

Fungi can produce various analogues and derivatives of this compound. nih.govresearchgate.netnih.govresearchgate.netacs.orgacs.org

Naturally occurring this compound enantiomers have been isolated from fungal sources. For example, the mangrove-derived fungus Nigrospora sp. QQYB1 has been shown to produce this compound enantiomers with four different absolute configurations: (2S, 6'S), (2R, 6'R), (2S, 6'R), and (2R, 6'S). nih.govresearchgate.netnih.gov These represent the first reported instances of such enantiomers from fungi. nih.govresearchgate.netnih.gov

Brominated this compound derivatives can also be produced by fungi, sometimes through manipulation of the culture medium. The addition of NaBr to the culture medium of Nigrospora sp. QQYB1 resulted in the successful production of brominated this compound derivatives. nih.govresearchgate.netnih.gov Compounds 9-12 from this study represent the first successful production of such derivatives from fungi via this method. nih.govresearchgate.netnih.gov

Table 1: Key Genes in this compound Biosynthesis

GenePutative FunctionRole in Biosynthesis
gsfANonreducing polyketide synthase (NR-PKS)Initiates biosynthesis by combining acetyl-CoA and malonyl-CoA to form heptaketide backbone. nih.govoup.com
gsfB, gsfCO-methyltransferasesMethylate phenols on intermediates. nih.govoup.com
gsfDO-methyltransferaseMethylates at the 5-OH position. nih.govoup.com
gsfEEnoyl reductaseCatalyzes enoyl reduction. nih.govoup.com
gsfFCytochrome P450 oxygenaseInvolved in grisan core formation via phenol oxidative activity. dtu.dknih.gov
gsfIHalogenaseChlorinates intermediates. dtu.dknih.govoup.com
gsfR1Putative transcription factorInvolved in regulation, can be negative or positive depending on conditions. nih.govnih.govmdpi.comresearchgate.net
gsfR2Putative transcription factorMay be involved in different pathways. nih.govmdpi.com
gsfKPutative NADP-dependent oxidoreductaseRole in biosynthesis debated, deletion may not affect production in some strains. dtu.dknih.govoup.com

Table 2: Influence of Nutritional Factors on this compound Production

StrainSignificantly Influencing Nutrients
Penicillium griseofulvum MTCC 1898Sucrose, K2HPO4, NaNO3, FeSO4·7H2O
Penicillium griseofulvum MTCC 2004Lactose, Glucose, MnSO4·H2O

Table 3: this compound Analogues and Derivatives from Fungal Sources

Source FungusType of Analogues/Derivatives ProducedExamples
Nigrospora sp. QQYB1Naturally Occurring Enantiomers, Brominated DerivativesEnantiomers with (2S, 6'S), (2R, 6'R), (2S, 6'R), (2R, 6'S) configurations; Brominated compounds (e.g., compounds 9-12). nih.govresearchgate.netnih.gov
Penicillium griseofulvumVarious analogues (e.g., penigriseofulvins A-F)Penigriseofulvins A-F (compounds 1-6). nih.gov
Arthrinium sp.Chlorinated and known analogues(+)-5-chlorothis compound, this compound, dechlorothis compound. researchgate.net

Molecular Mechanisms of Action

Antifungal Mode of Action

The antifungal activity of griseofulvin is primarily attributed to its interference with fundamental cellular processes in susceptible fungi. droracle.aipatsnap.com This includes disrupting microtubule function and mitosis, inhibiting nucleic acid synthesis, and impacting fungal cell wall synthesis. msdvetmanual.comdroracle.ainih.gov

Disruption of Fungal Microtubule Function and Mitosis

A key mechanism by which this compound exerts its fungistatic effect is by targeting fungal microtubules, essential components of the cytoskeleton involved in various cellular processes, including cell division. drugbank.commsdvetmanual.compatsnap.com By interfering with microtubule function, this compound disrupts the formation and operation of the mitotic spindle, which is crucial for chromosome segregation during mitosis. msdvetmanual.compatsnap.com This disruption ultimately leads to the inhibition of fungal cell division. patsnap.com The biological activity of this compound towards fungi is characterized by nuclear and mitotic abnormalities, followed by distortions in hyphal morphology. nih.govdroracle.ai

Binding to Alpha and Beta Tubulin

This compound is understood to bind to tubulin, the protein subunit that polymerizes to form microtubules. drugbank.compatsnap.com Specifically, it is thought to bind to both alpha and beta tubulin subunits. drugbank.commdpi.com Studies have suggested potential binding sites for this compound in tubulin, including one that may overlap with the binding site of paclitaxel and another located at the interface of alpha and beta tubulin. mdpi.commdpi.com This binding interferes with the normal function of microtubules. wikipedia.orgmdpi.com

Inhibition of Spindle Microtubule Dynamics and Polymerization

This compound inhibits microtubule polymerization, particularly affecting the dynamics of spindle microtubules. patsnap.commdpi.comaacrjournals.org While high concentrations of this compound (>100 µM) may be required to inhibit microtubule polymerization in vitro, lower concentrations (1-20 µM) have been shown to strongly suppress the dynamic instability of microtubules. droracle.aipnas.orgpnas.orgnih.govnih.gov This suppression of dynamic instability, which is vital for spindle assembly and function, is considered a primary mechanism by which this compound inhibits mitosis. mdpi.compnas.orgpnas.org The drug acts directly at the plus ends of microtubules, increasing their stability and suppressing their shortening rate. mdpi.com

Induction of Mitotic Arrest at Metaphase

The disruption of spindle microtubule function by this compound leads to the arrest of fungal cell division at the metaphase stage of mitosis. drugbank.comdroracle.aipnas.org This occurs because the proper formation and function of the mitotic spindle are necessary for chromosomes to align correctly at the metaphase plate and subsequently segregate into daughter cells. patsnap.com By interfering with these processes, this compound prevents the cell from progressing through mitosis, resulting in mitotic arrest and inhibition of fungal growth. drugbank.comdroracle.aipnas.org Cytological effects observed in various cell systems treated with this compound include C-mitoses, multipolar mitoses, and multinuclearity. nih.govdroracle.ai

Inhibition of Nucleic Acid Synthesis

Beyond its effects on microtubules, this compound is also thought to inhibit nucleic acid synthesis in fungi. drugbank.commsdvetmanual.comdroracle.ai Research has indicated that during growth inhibition, this compound can temporarily halt the net synthesis of nucleic acids and decrease the incorporation of precursors like uridine and thymidine into fungal nucleic acids. nih.gov This interference with DNA and RNA synthesis further contributes to its fungistatic activity. msdvetmanual.compatsnap.com

Mechanism of Action ComponentDescription
Binding to TubulinThis compound binds to alpha and beta tubulin subunits, interfering with microtubule function. drugbank.commdpi.com
Inhibition of Microtubule PolymerizationHigh concentrations inhibit polymerization; lower concentrations suppress dynamic instability. droracle.aipnas.orgpnas.orgnih.govnih.gov
Disruption of Mitotic Spindle FunctionInterferes with spindle formation and chromosome segregation. msdvetmanual.compatsnap.com
Induction of Mitotic ArrestCauses cell cycle arrest at the metaphase stage. drugbank.comdroracle.aipnas.org
Inhibition of Nucleic Acid SynthesisDecreases incorporation of precursors into DNA and RNA. nih.gov
Impact on Fungal Cell Wall SynthesisMay impair the synthesis of the fungal cell wall. msdvetmanual.comdroracle.ai

Non-Antifungal Cellular and Molecular Interactions

Antitumor Mechanisms of Action

This compound has demonstrated significant antitumor activity against a variety of cancer cell types, including cervical cancer, breast cancer, non-small-cell lung cancer, colorectal cancer, and adrenocortical cancer. frontiersin.orgnih.gov Its antitumor effects are mediated through several key mechanisms that target the fundamental processes of cancer cell growth and division. frontiersin.orgnih.gov

Inhibition of Cancer Cell Division and Proliferation

This compound inhibits the proliferation of various tumor cells by affecting the function of spindle microtubules during mitosis. frontiersin.orgnih.gov This inhibition of cell division contributes significantly to its antitumor effects. Studies have shown that this compound can inhibit the proliferation of cancer cells from lung, colorectal, breast, cervical, and liver tissues. frontiersin.orgnih.gov The concentrations of this compound necessary for the inhibition of cell proliferation are similar to those required for the induction of multipolar spindles and mitotic arrest. aacrjournals.org

Induction of Mitotic Arrest and Cell Death in Cancer Cells

A key antitumor mechanism of this compound involves the induction of mitotic arrest, primarily at the G2/M phase of the cell cycle, and subsequent cell death in cancer cells. frontiersin.orgiiarjournals.orgnih.govekb.eg This arrest is associated with various mitotic abnormalities, such as misaligned chromosomes and the formation of multipolar spindles. ekb.egresearchgate.net Studies have shown that this compound induces G2/M phase arrest in a dose-dependent manner in certain cancer cell lines. frontiersin.org The mechanisms underlying this compound-induced G2/M arrest include the induction of abnormal mitotic spindle formation, elevation of cyclin B1/cdc2 kinase activity, and down-regulation of myt-1 protein expression. iiarjournals.orgnih.gov Following mitotic arrest, this compound can induce apoptosis, a form of programmed cell death, in various tumor cells. frontiersin.orgnih.goviiarjournals.org Mechanisms of this compound-induced apoptosis include caspase 3 activation, Bcl-2 hyperphosphorylation, and inhibition of the normal function of Bcl-2 associated with Bax. iiarjournals.orgnih.gov this compound has been shown to induce apoptosis in colorectal cancer cells by increasing the expression of caspase-3, PARP, and Bax, while decreasing Bcl-2 protein expression. frontiersin.org In human testicular germ cell tumor cells, this compound can induce apoptosis by activating the expression of Cx43, caspase-9, and caspase-3. frontiersin.org

Table 1: Effects of this compound on Cell Cycle and Apoptosis in Cancer Cells

Cancer Cell LineEffect on Cell CycleEffect on ApoptosisKey MechanismsSource
Cervical cancer (HeLa)G2/M arrestApoptosisInhibition of mitotic spindle microtubule organization, centrosomal clustering, increased Cx43 and caspase-3 expression. frontiersin.orgresearchgate.net
Breast cancer (MCF-7)G2/M arrestApoptosisG2/M phase arrest in a dose-dependent manner, caspase 3 activation, Bcl-2 hyperphosphorylation. frontiersin.orgiiarjournals.orgresearchgate.net
Colorectal cancerG2/M arrestApoptosisIncreased caspase-3, PARP, Bax expression; decreased Bcl-2 expression. frontiersin.orgnih.gov
Multiple myeloma & LeukemiaInhibition of proliferation, ApoptosisApoptosisDynamic instability of microtubules, abnormal chromosome separation/connection. frontiersin.org
Human testicular germ cell tumor (JKT-1)Not specifiedApoptosisActivation of Cx43, caspase-9, and caspase-3 expression. frontiersin.org
Interaction with Mitotic Spindle Microtubules in Cancer Cells

This compound exerts its antitumor effects, in part, by interacting with mitotic spindle microtubules. frontiersin.orgekb.egresearchgate.netmdpi.com It is known to disrupt cell microtubule dynamics and cause cell death in cancer cells through binding to tubulin protein. mdpi.com While high concentrations (>100 μM) of this compound may be required to inhibit microtubule polymerization in vitro, much lower concentrations (1-20 μM) can effectively suppress the dynamic instability of microtubules. iiarjournals.orgpnas.orgnih.gov This suppression of spindle microtubule dynamics is considered a primary mechanism by which this compound inhibits mitosis in human cells, similar to the actions of other antimitotic drugs like vinca alkaloids and taxanes. iiarjournals.orgpnas.orgnih.govnih.gov this compound has been suggested to bind to tubulin at sites that overlap with the binding site of paclitaxel or within microtubule dimers. frontiersin.orgresearchgate.netnih.gov

Inhibition of Centrosomal Clustering

Many tumor cells contain supernumerary centrosomes, which can lead to the formation of multipolar mitotic spindles and chromosome segregation defects. To maintain mitotic stability, these multiple centrosomes often cluster into two functional spindle poles. aacrjournals.orgnih.govacs.org this compound has been identified as an inhibitor of this centrosomal clustering in cancer cells. aacrjournals.orgnih.govaacrjournals.orgfocusbiomolecules.com By inhibiting centrosome coalescence, this compound forces tumor cells with supernumerary centrosomes to undergo multipolar mitoses, which subsequently leads to apoptosis. aacrjournals.orgnih.govaacrjournals.orgfocusbiomolecules.com This inhibition of centrosomal clustering by this compound is not limited to mitotic cells but can also occur during interphase. aacrjournals.orgnih.gov The mechanism may involve the disruption of the interphase microtubule network. aacrjournals.org

Activation of Tumor Suppressor Protein p53

This compound has been shown to activate the tumor suppressor protein p53. aacrjournals.orgekb.egnih.govbohrium.com Activated p53 plays a critical role in the cellular response to stress, including DNA damage and oncogene activation, by inducing cell cycle arrest or apoptosis. wikipedia.orgcusabio.comyoutube.com Increased p53 accumulation in the nucleus of cancer cells treated with this compound has been observed, indicating that these cells are undergoing apoptosis. ekb.egresearchgate.netresearchgate.netmdpi.com The activation of p53 by this compound contributes to its ability to induce mitotic arrest and subsequent cell death in cancer cells. aacrjournals.orgekb.egnih.govbohrium.com

Activation of Wnt Pathway in Myeloma

Exaggerated Wnt/β-catenin signaling has been observed in lymphoma and multiple myeloma (MM), suggesting that targeting this pathway could be a therapeutic approach. This compound, which is chemically related to known Wnt inhibitors, has shown potential in this regard. Studies have found that this compound can inhibit the Wnt/β-catenin signaling pathway in myeloma cell lines and induce apoptosis. iiarjournals.orgnih.govfrontiersin.orgnih.gov In vitro and in vivo studies indicate that this compound can inhibit the proliferation of myeloma cells and significantly reduce tumor growth by influencing the Wnt pathway and decreasing the phosphorylation of the β-catenin pathway. frontiersin.org

Induction of Apoptosis in Cancer Cell Lines

This compound has demonstrated the ability to induce apoptosis in a variety of cancer cell lines. nih.govnih.govmedchemexpress.comtoku-e.comresearchgate.net This effect has been observed in multiple myeloma, lymphoma, colorectal cancer, liver cancer, and leukemia cells. iiarjournals.orgnih.govmedchemexpress.comiiarjournals.org The induction of apoptosis is often dose-dependent. iiarjournals.orgmedchemexpress.comiiarjournals.org For instance, this compound significantly induced apoptosis in various myeloma and lymphoma cell lines in a dose-dependent manner, while healthy control cells were less sensitive. iiarjournals.orgnih.goviiarjournals.org In colorectal cancer cells, this compound induced apoptosis by increasing the expression of caspase-3, PARP, and Bax, while decreasing Bcl-2 expression. nih.gov this compound-promoted abnormal microtubule stabilization has been shown to initiate a cascade of events leading to apoptosis. iiarjournals.orgiiarjournals.org

The half-maximal inhibitory concentration (IC₅₀) values for this compound vary depending on the cancer cell line. The following table summarizes some reported IC₅₀ values:

Cell LineCancer TypeIC₅₀ (µM)Citation
KMS 18Multiple Myeloma9 nih.govmedchemexpress.com
OPM-2Multiple Myeloma45 medchemexpress.com
RPMI-8226Multiple Myeloma26 medchemexpress.com
U-266Multiple Myeloma18 medchemexpress.com
MPC-11Multiple Myeloma44 medchemexpress.com
RajiLymphoma33 iiarjournals.orgiiarjournals.org
SU-DHL-4Lymphoma22 iiarjournals.orgnih.goviiarjournals.org
Oci Ly 8 Lam 53Lymphoma30 iiarjournals.orgiiarjournals.org
Primary CLL cellsLeukemia80 iiarjournals.orgiiarjournals.org
COLO 205Colon CancerNot specified medchemexpress.com
HT 29Colon CancerNot specified medchemexpress.com
Hep G2Liver CancerNot specified medchemexpress.com
Hep 3BLiver CancerNot specified medchemexpress.com
HL 60LeukemiaNot specified medchemexpress.com
MCF-7Breast Cancer17 nih.govfrontiersin.org
NCI-H446Small Cell Lung Cancer24.58 ± 1.32 nih.govfrontiersin.org
SCC114Oral Squamous Cell Carcinoma6.4 nih.gov
NCI-H295RAdrenocortical CarcinomaNot specified nih.gov

This compound can also induce G₂/M cell cycle arrest in cancer cells, contributing to its anti-tumor effects. iiarjournals.orgmedchemexpress.com Higher doses (>20 µM) in HT 29 colorectal adenocarcinoma cells initiated significant G₂/M arrest. iiarjournals.org

Inhibition of Cancer Cell Migration, Invasion, and Adhesion

This compound has shown inhibitory effects on the migration, invasion, and adhesion of tumor cells. nih.govresearchgate.net Studies have demonstrated that this compound can significantly inhibit the longitudinal migration of cells at higher concentrations. nih.gov The inhibition rate of cell adhesion ability has also been shown to increase with increasing this compound concentration. nih.gov

Antiviral Mechanisms of Action

Inhibition of Hepatitis C Virus Replication by Disrupting Microtubule Polymerization

This compound has been shown to suppress Hepatitis C Virus (HCV) replication in vitro. nih.goviiarjournals.orgresearchgate.netniph.go.jpekb.egfishersci.camdpi.com This antiviral effect is thought to be related to its interaction with microtubules. iiarjournals.orgniph.go.jpekb.egmdpi.comnih.gov this compound can inhibit microtubule polymerization and arrest human cells in the G₂/M phase. niph.go.jpekb.eg It is speculated that this inhibition of microtubule polymerization may influence the formation of the HCV-RNA replication complex. niph.go.jp Studies using Huh7/Rep-Feo cells (a hepatoma cell line containing HCV replicons) showed dose-dependent antiviral effects with this compound. niph.go.jp Immunostaining of Huh7.5.1/JFH-1 cells (cells persistently infected with HCV) treated with this compound revealed a substantial reduction in HCV NS3 protein expression, indicating suppression of HCV replication. niph.go.jp

Potential Interactions with SARS-CoV-2 Targets (Main Protease, RdRp, Spike Protein Receptor-Binding Domain, ACE2 Receptor)

Computational studies have explored the potential of this compound and its derivatives as therapeutic agents for COVID-19 by examining their interactions with key SARS-CoV-2 targets. iiarjournals.orgfishersci.canih.govdntb.gov.uanih.gov Molecular docking analysis revealed that this compound has binding potential with the SARS-CoV-2 main protease, RNA-dependent RNA polymerase (RdRp), spike protein receptor-binding domain (RBD), and the human host angiotensin-converting enzyme 2 (ACE2). iiarjournals.orgnih.govdntb.gov.uanih.govdoaj.org this compound showed the highest docking score with the main protease of SARS-CoV-2 in one study. nih.govdntb.gov.uanih.govresearchgate.net These findings suggest that this compound may have inhibitory effects on SARS-CoV-2 entry and viral replication, although these are based on computational approaches and warrant further investigation. nih.govdntb.gov.ua

Anti-Inflammatory and Immunomodulatory Potential

Beyond its antifungal and potential antineoplastic and antiviral effects, this compound has also demonstrated anti-inflammatory and immunomodulatory properties. nih.govtaylorandfrancis.comiiarjournals.orgnih.govfrontiersin.orgekb.egresearchgate.net It has shown effectiveness in treating non-fungal skin inflammation conditions, such as pigmented purpuric dermatosis and lichen planus. nih.govnih.gov this compound has been shown to induce inhibitory effects on vascular cell adhesion molecule 1 (VCAM-1) in human dermal microvascular endothelial cells stimulated with TNF-alpha and IL-1. nih.gov These observations suggest a potential role for this compound in modulating inflammatory responses. taylorandfrancis.comnih.gov

Cardiovascular Effects: Vasodilation and Capillary Blood Flow Improvement

This compound has been observed to potentially influence the cardiovascular system, specifically by contributing to vascular vasodilation and improving capillary blood flow. wikipedia.orgnih.govchem960.comguidetopharmacology.orgreadthedocs.io While these effects have been noted, the precise molecular mechanism underlying this compound's impact on blood pressure and blood flow is not yet fully elucidated. nih.gov One hypothesis suggests that this compound may interact with ACE2, potentially enhancing its function, which could contribute to vasodilation and tissue protection. nih.gov

Interaction with Keratin Intermediate Filament Proteins (K8 and K18)

Studies indicate that this compound and its metabolites, specifically 6-desmethylthis compound (6-DMG) and 4-desmethylthis compound (4-DMG), exhibit favorable interactions with cytokeratin intermediate filament proteins K8 and K18. wikipedia.orgchem960.comguidetopharmacology.org These interactions are considered potentially responsible for observed liver injury and the formation of Mallory bodies in hepatocytes of humans, mice, and rats treated with this compound. wikipedia.orgchem960.comguidetopharmacology.org Molecular docking analysis has been used to evaluate the binding affinities of this compound and its metabolites with K8 and K18 across different species. chem960.com

The binding energy values from molecular docking studies illustrate the interactions between this compound, its metabolites, and keratin proteins. For instance, this compound showed binding energies towards K8 ranging from -3.17 to -4.6 kcal/mol. Higher binding energies towards K18 were noted in rat and mouse models compared to humans, which might explain the differences in the severity of hepatitis observed between these species. chem960.comguidetopharmacology.org this compound has also been shown to induce the phosphorylation of K8 (at serine residues 79 and 436) and K18 (at serine residue 33).

CompoundTarget ProteinSpeciesBinding Energy (kcal/mol)
This compoundK8Human-3.17 to -4.6
This compoundK18Rat-5.23
This compoundK18Mouse-5.54
6-desmethylthis compoundK8/K18Human-3.34 to -5.61
4-desmethylthis compoundK8/K18Human-3.34 to -5.61

Note: Binding energy ranges for metabolites represent favorable interactions with K8 and K18 across species. Specific values for each metabolite and species within the cited range were not consistently detailed for inclusion in this summary table. wikipedia.orgchem960.comguidetopharmacology.org

Inhibition of Ferrochelatase (FECH) and its Metabolites

This compound acts as an inhibitor of ferrochelatase (FECH) as an off-target effect. FECH is a crucial enzyme in the heme biosynthesis pathway, catalyzing the insertion of ferrous iron into protoporphyrin IX (PPIX) to form heme. In vivo, this compound is metabolized to N-methylprotoporphyrin (NMPP), which is a potent inhibitor of FECH. Inhibition of FECH by this compound or NMPP has been shown to impact angiogenesis in various models. NMPP is described as a tight-binding competitive inhibitor of purified ferrochelatase with a nanomolar Ki value.

Structure-activity Relationships Sar and Analogue Development

Elucidation of SAR for Antifungal Activity

The antifungal activity of griseofulvin is primarily attributed to its ability to disrupt fungal mitosis by binding to tubulin. Studies on this compound analogues have provided insights into the structural requirements for this activity.

Impact of Substituents at Specific Positions (C-6, C-7, C-6', Carbonyl, Double Bond)

Substituents at various positions on the this compound core structure, as well as the presence and position of carbonyl groups and double bonds, have been shown to significantly affect antifungal activity. For instance, research on new this compound derivatives isolated from the mangrove-derived fungus Nigrospora sp. QQYB1 demonstrated that substituents at C-6, C-7, and C-6', along with the positions of the carbonyl and double bond, play a crucial role in their antifungal activity. nih.govnih.gov

SAR for Anticancer Activity

Beyond its antifungal uses, this compound has garnered attention for its antiproliferative activity in cancer cells, particularly through the inhibition of centrosomal clustering. researchgate.netnih.gov The SAR for this anticancer activity shows both similarities and differences compared to its antifungal SAR. researchgate.netnih.govnih.gov

Modifications at 4, 5, 2', 3', and 4' Positions

Modifications to the this compound structure at positions 4, 5, 2', 3', and 4' have been explored to understand their impact on anticancer activity. Studies indicate that modifications at the 4 and 5 positions often result in inactive molecules. researchgate.netnih.gov The presence of an enol ether at the 2' position and an sp2 hybridized 4' position appear to be important for activity. researchgate.netnih.gov

Identification of Potent Analogues (e.g., 2'-benzyloxy this compound)

Several analogues with enhanced anticancer potency have been identified. The 2'-benzyloxy and 2'-(4-methylbenzyloxy) analogues, as well as the oxime of the former, have shown significantly increased activity compared to this compound in inhibiting centrosomal clustering. researchgate.netnih.gov For example, the 2'-benzyloxy analogue has demonstrated a 25-fold increase in activity as a centrosome clustering inhibitor compared to this compound in certain cancer cell lines. researchgate.netnih.gov 2'-benzyloxy-2'-demethoxy-griseofulvin has also been highlighted as one of the most effective compounds against certain breast cancer cell lines. nih.govcore.ac.ukfrontiersin.org While these potent analogues show promise, challenges such as poor aqueous solubility and metabolic stability, similar to the parent compound, have been observed, prompting further analogue development to improve pharmacokinetic properties. researchgate.netnih.gov The 2'-benzylamine analogue has been identified as a promising compound with improved solubility and metabolic stability while retaining low micromolar in vitro anticancer potency. nih.gov

Computational Design and In Silico Studies of this compound Derivatives

Computational methods, such as molecular docking and dynamics simulations, are increasingly utilized in the design and evaluation of this compound derivatives. These in silico studies provide valuable insights into the potential interactions of these compounds with biological targets. mdpi.comresearchgate.netnih.gov

Molecular Docking and Dynamics Simulations for Target Binding Affinity

This compound, a spiro-containing antifungal antibiotic derived from Penicillium species, has been a subject of ongoing research not only for its antifungal properties but also for potential antibacterial and anticancer activities. Investigations into its structure-activity relationships (SAR) and the development of analogues aim to enhance its therapeutic efficacy and explore new applications.

Design of Novel Analogues with Enhanced Antibacterial Activity

The urgent need for innovative antibiotics has driven theoretical investigations into designing novel this compound analogues with enhanced antibacterial efficacy. Computational studies have been employed to design derivatives and evaluate their interactions with bacterial targets using in silico analysis. mdpi.comresearchgate.netresearchgate.net Researchers hypothesized that this compound and its newly designed derivatives might favorably interact with the FtsZ protein in bacterial cells, given its structural similarity to microtubules, the primary targets of this compound in eukaryotic cells. mdpi.comresearchgate.net

In silico studies investigating the binding affinities and stability towards potential bacterial targets revealed that newly designed this compound derivatives displayed robust binding affinities towards PBP2, tyrosine phosphatase, and FtsZ proteins. mdpi.comresearchgate.netresearchgate.net Molecular dynamics (MD) simulations further underscored the notable stability of these derivatives when engaged with the FtsZ protein. mdpi.comresearchgate.netresearchgate.net

Structure analysis of computationally designed derivatives indicated that the presence of substituents such as β-lactam moiety, hydrazine, sulfonyl group, chlorine, and methylenedioxy ring groups can be beneficial for antibacterial activity. mdpi.com Experimental testing of antibacterial activity for previously synthesized this compound derivatives has been performed on panels of gram-positive and gram-negative microorganisms using the microdilution method to determine minimal inhibitory (MIC) and minimal bactericidal (MBC) concentrations. researchgate.netresearchgate.net Some tested compounds exhibited potent antibacterial activity against studied bacteria, with MIC and MBC values often exceeding the activity of reference drugs like ampicillin and streptomycin. researchgate.netresearchgate.net

Preliminary SAR studies on related compounds, such as geodin derivatives which share the grisan backbone with this compound, have indicated that the introduction of halogenated benzyl groups, particularly fluorobenzyl, and substitution of the 4-OH group could be key factors in increasing antibacterial activities. mdpi.com

Synthesis of this compound Analogues for Targeted Research

The synthesis of this compound analogues is crucial for targeted research aimed at understanding their biological activities and improving their properties, such as solubility and potency. While this compound was initially produced microbiologically, efforts have been made to synthesize the complex molecule chemically to permit the study of improved methods and the preparation of analogues not accessible by fermentation. google.com

Various strategies have been employed for the de novo synthesis of this compound analogues, including oxidative cyclisation, Diels-Alder reactions, double Michael addition, and Dieckmann cyclization. dtu.dk These methods allow for modifications at different positions of the this compound structure, such as the A, B, and C rings, which may not be possible through modifications of the natural product. dtu.dk For instance, Diels-Alder cycloaddition of alkylidene ketones with modified 1,3-butadienes has been used to synthesize analogues with modifications on the C ring, such as at the 6'-position. tandfonline.com

Modifications have been explored at various positions, including the 4, 5, 6, 2', 3', and 4' positions. mdpi.comresearchgate.netacs.org Studies have shown that modifications at the 4 and 5 positions can lead to inactive molecules. researchgate.netacs.org The presence of the enol ether at the 2' position and an sp2 hybridized 4' position appear important for certain activities. researchgate.netacs.org Analogues with structural modifications at positions like 4, 5, 6, 2', 3', and 4' have been synthesized and tested for various activities, including antifungal and anticancer properties. mdpi.comresearchgate.netacs.org

Specific synthetic efforts have focused on developing analogues with improved water solubility, which is a known limitation of this compound. researchgate.netasianpubs.orgnih.gov For example, six new this compound analogues were synthesized and tested for antiproliferative activity and water solubility, with some exhibiting higher water solubility than this compound and its 2'-benzyloxy analogue. researchgate.netnih.gov

Research findings from the synthesis and evaluation of analogues provide valuable data on the correlation between structural modifications and biological activities. For example, studies have investigated the influence of a 6'-methyl group in ring C on fungicidal activity tandfonline.com and the impact of modifications at the 4'-position on potential anticancer properties related to microtubule dynamics. bohrium.com

While comprehensive data tables covering all synthesized analogues and their activities are extensive and typically found within the primary research articles, the following provides illustrative examples of types of data presented in such studies, based on the search results:

Table: Illustrative Antibacterial Activity Data for this compound Analogues (Example Structure)

CompoundStructural Modification (Illustrative)MIC (µM) against S. aureus (Illustrative)MBC (µM) against S. aureus (Illustrative)Reference
This compound->16>16Based on mdpi.com
Analogue A4-bromobenzyl derivative17.60- mdpi.com
Analogue B3-iodobenzyl derivative16.25- mdpi.com
Analogue CChlorobenzyl analogue4.77- mdpi.com

Research on synthesized analogues also includes evaluating their effects on cellular processes, such as inhibition of centrosomal clustering in cancer cells or induction of mitotic arrest and apoptosis. researchgate.netnih.govbohrium.com These studies contribute to understanding the mechanism of action of this compound derivatives and identifying promising candidates for further investigation.

Pharmacological Research and Therapeutic Efficacy

Antifungal Efficacy Studies

Research into the antifungal efficacy of griseofulvin has encompassed in vitro studies to determine its spectrum of activity and in vivo models to assess its effectiveness in living organisms. Clinical trials have also evaluated its efficacy in specific dermatophyte infections, particularly tinea capitis, and compared it with other antifungal agents.

In Vitro Antifungal Spectrum (e.g., Microsporum, Epidermophyton, Trichophyton species)

In vitro studies have investigated the susceptibility of various dermatophyte species to this compound. These studies typically determine the minimum inhibitory concentration (MIC), which is the lowest concentration of the drug that inhibits visible fungal growth.

Research has shown that this compound exhibits antifungal activity against common dermatophytes, including species of Microsporum, Epidermophyton, and Trichophyton. For instance, studies have examined the susceptibility of Trichophyton mentagrophytes, T. verrucosum, Microsporum canis, and Epidermophyton floccosum to this compound, reporting MIC values within a certain range nih.gov. Another study evaluating the in vitro susceptibility of dermatophytes, including Microsporum canis, Microsporum gypseum, Trichophyton mentagrophytes, Trichophyton rubrum, Trichophyton schoenleinii, and Epidermophyton floccosum, also determined MIC values for this compound researchgate.net. While some studies indicate that certain isolates, such as T. verrucosum, M. canis, and T. mentagrophytes, may exhibit relatively higher MIC values suggesting potential reduced susceptibility, the majority of isolates tested generally fall within a susceptible range nih.gov.

However, the in vitro efficacy can vary depending on the specific fungal species and the methodology used for susceptibility testing oup.commedicinearticle.com. For example, one study found that all Microsporum spp. and Epidermophyton spp. strains tested were resistant to fluconazole and this compound, while Trichophyton spp. showed varying resistance rates to different antifungals, including this compound (46.4% resistance in that specific study) oamjms.eu. Conversely, another study indicated that the MIC range for isolated dermatophytes against this compound was within the normal susceptibility range of a standard strain (Trichophyton mentagrophytes ATCC MYA – 4439), suggesting susceptibility of the isolates tested medicinearticle.com.

The following table summarizes representative in vitro susceptibility data for this compound against various dermatophyte species:

Dermatophyte SpeciesMIC Range (µg/mL)NotesSource
Trichophyton mentagrophytes0.43-0.95Geometric mean MIC range for tested isolates nih.gov
T. verrucosum0.43-0.95Geometric mean MIC range for tested isolates nih.gov
Microsporum canis0.43-0.95Geometric mean MIC range for tested isolates nih.gov
Epidermophyton floccosum0.43-0.95Geometric mean MIC range for tested isolates nih.gov
Trichophyton spp.-46.4% resistance reported in one study oamjms.eu
Microsporum spp.-100% resistance reported in one study oamjms.eu
Epidermophyton spp.-100% resistance reported in one study oamjms.eu

Note: MIC values and resistance rates can vary significantly between studies due to differences in methodologies, fungal isolates, and geographical locations.

In Vivo Efficacy Models (e.g., Guinea Pig Model of Trichophytosis)

In vivo models are crucial for evaluating the effectiveness of antifungal agents in a living system. The guinea pig model of dermatophytosis, particularly infection with Trichophyton mentagrophytes, is a widely used model for assessing the in vivo efficacy of antifungal drugs, including this compound karger.comkarger.comnih.govresearchgate.net.

Studies utilizing this model have demonstrated the in vivo antifungal activity of both topical and oral administration of this compound against Trichophyton mentagrophytes infections in guinea pigs karger.comkarger.com. For example, a study evaluating a novel topical formulation of this compound in a guinea pig model of trichophytosis showed effective cure of infected animals nih.gov. This model allows for the assessment of clinical and mycological cure, providing valuable data on the drug's effectiveness in reducing infection severity and eliminating the fungus from infected tissues karger.comresearchgate.net. The model typically involves inducing infection with a standardized inoculum of dermatophytes and then administering the antifungal treatment, monitoring the progression of the infection and the response to therapy through clinical scoring, microscopy, and fungal cultures karger.comresearchgate.net.

Efficacy in Specific Dermatophytosis (e.g., Tinea Capitis)

This compound has been a traditional treatment for tinea capitis, a common dermatophyte infection of the scalp, particularly in children ijcmph.compracticeupdate.comjwatch.org. Numerous studies and meta-analyses have investigated its efficacy in treating this condition.

While newer agents like terbinafine are increasingly used, often offering shorter treatment durations, this compound has remained an important option, especially for Microsporum infections ijcmph.comjwatch.org. Comparative studies have provided data on its cure rates in relation to other treatments (see Section 5.1.4).

Comparative Efficacy with Other Antifungal Agents (e.g., Terbinafine, Fluconazole, Azoles)

Comparative studies have evaluated the efficacy of this compound against other systemic antifungal agents commonly used for dermatophyte infections, such as terbinafine, fluconazole, and other azoles. These comparisons are important for determining the optimal treatment strategies for different types of dermatophytosis and causative species.

Comparisons with fluconazole have also been conducted. One study comparing this compound, terbinafine, and fluconazole for tinea capitis in children reported cure rates of 96% for this compound, 88% for terbinafine, and 84% for fluconazole researchgate.netnih.gov. Another study comparing this compound and fluconazole for tinea capitis found no significant difference in efficacy, although higher doses were associated with earlier cure practiceupdate.com.

Studies comparing this compound with azoles and allylamines for tinea corporis have suggested that azole and allylamine agents may have greater efficacy in some cases ijpmbs.com. However, the choice of antifungal agent often depends on the specific fungal species involved oamjms.euijcmph.comresearchgate.netresearchgate.net.

The following table summarizes comparative efficacy findings from selected studies:

ComparisonInfection TypeKey FindingsSource
This compound vs. TerbinafineTinea CapitisNo significant difference in overall efficacy; Terbinafine superior for Trichophyton, this compound superior for Microsporum. ijcmph.comjwatch.orgresearchgate.net
This compound vs. Terbinafine vs. FluconazoleTinea CapitisThis compound showed highest cure rate (96%), followed by Terbinafine (88%) and Fluconazole (84%) in one study. researchgate.netnih.gov
This compound vs. FluconazoleTinea CapitisNo significant difference in efficacy reported in one study. practiceupdate.com
This compound vs. Azoles/AllylaminesTinea CorporisAzoles and allylamines may show greater efficacy in some cases. ijpmbs.com

Non-Antifungal Efficacy Studies

Beyond its established antifungal properties, research has explored potential non-antifungal effects of this compound, particularly in the context of antitumorigenic activity.

In Vitro and In Vivo Antitumorigenic Effects

Studies have investigated the potential of this compound to inhibit the growth of tumor cells both in vitro and in vivo. This compound is known to interfere with microtubule function, a property that is relevant to cell division and could contribute to antitumor effects nih.govcapes.gov.br.

In vitro studies have demonstrated that this compound can inhibit the proliferation and induce apoptosis in various cancer cell lines. For example, it has been shown to inhibit the proliferation of human myeloma cell lines, mouse myeloma cell lines, and human lymphoma cell lines in a concentration-dependent manner, with reported IC50 values (the concentration required to inhibit cell growth by 50%) for different cell lines nih.goviiarjournals.org. Studies have also indicated that this compound can inhibit the proliferation of adrenocortical carcinoma cells and induce apoptosis in these cells in a dose-dependent manner in vitro nih.govuni-duesseldorf.de.

In vivo studies using animal models have also provided evidence of this compound's antitumorigenic effects. Research has shown that this compound can reduce the growth of myeloma in murine models nih.goviiarjournals.org. Additionally, in a nude mouse xenograft model, this compound was found to inhibit the growth of small-cell lung cancer cells nih.gov. These in vivo effects are thought to be mediated, in part, by influencing factors such as the expression of proteins involved in apoptosis and angiogenesis nih.gov.

Research suggests that this compound's antitumor effects may involve mechanisms related to the Wnt pathway and the inhibition of centrosomal clustering, which is a mechanism used by some cancer cells to manage supernumerary centrosomes nih.govnih.govuni-duesseldorf.de.

The following table summarizes some findings on the in vitro antitumorigenic effects of this compound:

Cancer Cell Line(s)Effect ObservedNotesSource
Human and murine myeloma/lymphoma cell linesInhibition of proliferation, apoptosis inductionDose-dependent effects, IC50 values reported nih.goviiarjournals.org
Adrenocortical carcinoma cells (NCI-H295R)Inhibition of proliferation, apoptosis inductionDose-dependent effects nih.govuni-duesseldorf.de
Small-cell lung cancer cells (NCI-H446)Inhibition of proliferation (in vitro and in vivo)In vivo effect observed in xenograft model nih.gov
Oral squamous cell carcinoma cells (SCC114)Inhibition of proliferationIC50 value reported nih.gov

Further research is ongoing to fully understand the mechanisms underlying the antitumorigenic effects of this compound and its potential therapeutic applications in oncology nih.govnih.goviiarjournals.orguni-duesseldorf.de.

Inhibition of Tumor Growth in Xenograft Mouse Models

Antiviral Activity in Cellular Models

This compound has demonstrated antiviral activity in cellular models, particularly against the hepatitis C virus (HCV). Studies have shown that this compound can inhibit the replication of the hepatitis C virus. frontiersin.orgnih.govekb.egnih.gov this compound suppresses HCV replication by arresting the human cell cycle at the G2/M phase and acting on microtubule polymerization. nih.gov It has been documented that the replication of a subgenomic hepatitis C virus genotype 1b (HCV-1b) replicon can be suppressed by this compound. nih.gov this compound decreased the replicon RNA titer in Huh7/Rep-Feo cells in vitro in a dose-dependent manner and was shown to induce G2/M cell cycle arrest in HCV replicon cells. nih.gov

Anti-Inflammatory Effects in Non-Fungal Skin Diseases

Research suggests that this compound possesses anti-inflammatory and immunomodulatory properties, which may contribute to its effects in non-fungal skin diseases. frontiersin.orgnih.govekb.egnih.gov Studies have reported the effectiveness of this compound in the treatment of non-fungal skin inflammation diseases, including lichen planus and chronic purpuric dermatosis. ekb.egnih.gov An older study suggested that this compound has an anti-inflammatory effect, estimated to be in the range of one-third to one-tenth of that of cortisone acetate. bmj.com This anti-inflammatory effect may explain some of the reported benefits of this compound in conditions other than ringworm infections. bmj.com

Angiogenic Inhibition in Preclinical Models (e.g., Choroidal Neovascularization)

This compound has shown potential as an inhibitor of angiogenesis in preclinical models, particularly in the context of ocular neovascularization, such as choroidal neovascularization (CNV). Ocular neovascularization is a key feature of blinding eye diseases like wet age-related macular degeneration (AMD). nih.govarvojournals.org Research has identified ferrochelatase (FECH), an enzyme in heme synthesis, as a mediator of ocular neovascularization. nih.govarvojournals.orgarvojournals.org this compound inhibits FECH as an off-target effect. nih.govarvojournals.orgarvojournals.org

In vitro studies using human retinal endothelial cells have shown that this compound and its active metabolite, N-methylprotoporphyrin (NMPP), dose-dependently inhibit the proliferation, migration, and tube formation of these cells. arvojournals.org this compound at concentrations of 50 µM or higher profoundly suppressed choroidal sprouting in an ex vivo assay. arvojournals.org

In the murine laser-induced choroidal neovascularization (L-CNV) model, this compound dose-dependently decreased CNV. arvojournals.org Intravitreal administration of 50 µM and 100 µM this compound reduced CNV volume by 28% and 67%, respectively. arvojournals.org Oral administration of 0.5% and 1% (w/w) this compound in food also reduced CNV volume by 33% and 42%, respectively. arvojournals.org this compound also inhibited neovascularization and decreased the avascular area in the mouse oxygen-induced retinopathy (OIR) model, a model of retinal angiogenesis. arvojournals.orgresearchgate.net These findings suggest that this compound has significant anti-angiogenic potential in the eye at clinically achievable concentrations. arvojournals.org

Combination Therapy Research

Investigating this compound in combination with other therapeutic agents is an area of research aimed at potentially enhancing efficacy or overcoming resistance.

Studies have explored the effects of combining this compound with other antifungal agents, particularly against dermatophytes, to address issues of resistance or improve treatment outcomes. In vitro studies have investigated the activities of berberine hydrochloride in combination with commonly used antifungal agents, including this compound, against Microsporum canis. researchgate.net While indifference was observed for the combination of allicin and this compound against M. canis, synergism was not observed either. frontiersin.org

Research using checkerboard dilution assays has examined the in vitro additive or synergistic effects of this compound in combination with other antifungals like terbinafine against multidrug-resistant dermatophytes. researchgate.netscielo.br Some combinations of this compound and terbinafine have shown additive effects against multidrug-resistant isolates. researchgate.netscielo.br The type of interaction (synergy, additive, or indifference) can vary depending on the specific drugs and fungal isolates tested. mdpi.com

Here is a summary of in vitro combination studies with other antifungal agents:

CombinationFungal Species/IsolatesInteraction Observed (In vitro)Source
Allicin + this compoundMicrosporum canisIndifference frontiersin.org
Berberine + this compoundMicrosporum canisSynergistic activity observed in some combinations. researchgate.net researchgate.net
This compound + TerbinafineMultidrug-resistant dermatophytesAdditive effects observed in some combinations. researchgate.netscielo.br researchgate.netscielo.br

Combinations with Other Therapeutic Agents (e.g., Prednisolone, Vincristine)

Research has investigated the efficacy of combining this compound with other drugs, particularly in cases where an inflammatory response complicates a fungal infection or in exploring potential anti-proliferative effects.

Combinations with Prednisolone

Prednisolone, a corticosteroid with anti-inflammatory properties, has been studied in combination with this compound for the treatment of inflammatory tinea capitis, such as kerion celsi. oup.comnih.govresearchgate.netnih.govresearchgate.net Kerion celsi is a severe inflammatory reaction to dermatophyte infections of the scalp, often seen in children, and can potentially lead to scarring alopecia if untreated. oup.com

A randomized, comparative trial evaluated the efficacy of oral this compound combined with oral prednisolone versus oral this compound alone in treating kerion celsi. oup.comnih.govresearchgate.net In this study, both groups received oral this compound for 8 weeks. oup.comnih.govresearchgate.net The combination group also received oral prednisolone in tapering doses for 3–4 weeks. oup.comnih.govresearchgate.net At the final evaluation at week 12, both treatment groups showed a 100% cure rate, with no significant difference observed in terms of clinical or mycological cure between the combination therapy and this compound alone. oup.comnih.govresearchgate.net This suggests that while both regimens were effective, the addition of prednisolone did not provide significant additional objective or subjective improvement in this specific context. oup.comnih.govresearchgate.net

Another study involving children with inflammatory tinea capitis treated with a combination of this compound and oral corticosteroids reported a fall in positive mycology from 100% to 16% at the end of 8 weeks. jpmi.org.pk In this study, 25% of patients achieved complete resolution of inflammation, initiation of hair growth, and negative mycological examination. jpmi.org.pk

Combinations with Vincristine

Vincristine is a vinca alkaloid chemotherapy medication known to bind to tubulin and interfere with microtubule function, similar to this compound's mechanism of action in fungi. nih.govnih.govuni.luguidetopharmacology.orgwikipedia.orgmdpi.com Research has explored the potential for synergistic effects when this compound is combined with vincristine, particularly in the context of cancer cell proliferation, given their shared target on microtubules. nih.gov

In in vitro experiments focusing on human breast cancer cells (MCF-7), this compound demonstrated a significant inhibitory effect on cell proliferation. nih.gov When this compound was used in combination with vincristine, a synergistic effect was observed in inhibiting MCF-7 cell proliferation. nih.gov Specifically, when this compound at 10 µM was combined with vincristine at 0.5 nM or 1 nM, the inhibitory effects on MCF-7 proliferation were reported as 84% and 92%, respectively. nih.gov This suggests that combining this compound with vincristine can enhance the therapeutic effect on these cancer cells. nih.gov The mechanism underlying this synergy may be related to their combined impact on microtubule dynamics and the activation of tumor suppressor proteins like p53. nih.gov

Advanced Drug Delivery Systems and Formulations

Strategies to Enhance Griseofulvin Bioavailability and Distribution

Efforts to improve this compound's bioavailability and distribution focus on increasing the systemic absorption of the drug and facilitating its transport to infected tissues. Various formulation techniques have been investigated to achieve these goals.

Nano- and Microcrystal Formulations

Particle size reduction to the nanoscale or microscale is a common strategy to enhance the dissolution rate and, consequently, the bioavailability of poorly soluble drugs. Studies on this compound have explored the use of nano- and microsuspensions, particularly for subcutaneous administration, as an alternative to the conventional oral route which is associated with low bioavailability. nih.govtaylorandfrancis.comtandfonline.com

Liposomal Formulations

Liposomes are versatile drug carriers that can encapsulate both hydrophilic and lipophilic drugs, offering potential benefits such as improved solubility, enhanced tissue penetration, and reduced toxicity. ijfmr.comijfmr.com For this compound, liposomal formulations have been investigated to enhance its delivery, particularly for topical applications in treating cutaneous fungal infections. ijfmr.com

Studies examining the oral bioavailability of this compound-loaded liposomes in rats have highlighted the impact of formulation parameters like encapsulation efficiency and liposome size. nih.govmdpi.com Encapsulation within liposomes was found to increase this compound bioavailability by 1.7 to 2.0 times compared to an aqueous suspension. nih.govmdpi.com A significant enhancement (approximately two-fold) in bioavailability was observed with liposomes exhibiting higher drug encapsulation efficiency. nih.govmdpi.com Furthermore, smaller liposome sizes (142 nm and 357 nm) resulted in approximately three times higher bioavailability compared to larger liposomes (813 nm). nih.govmdpi.com However, reducing the size below 400 nm did not lead to a further increase in uptake or bioavailability. nih.govmdpi.com These findings underscore the critical role of optimizing encapsulation efficiency and liposome size in the design of this compound liposomal formulations for improved oral bioavailability. nih.govmdpi.com The development of liposome-loaded topical films containing this compound is also being explored as a strategy for enhanced transdermal delivery and improved treatment of skin infections. ijfmr.comijfmr.com

Vaterite Carriers for Topical Delivery

Vaterite, a calcium carbonate polymorph, has emerged as a promising carrier for the topical delivery of this compound, especially for targeting fungal infections within hair follicles, which are often difficult to treat with conventional topical formulations due to this compound's poor skin permeation. researchgate.netnih.govacs.orgnih.gov

Novel topical formulations utilizing micron-sized vaterite carriers have been developed to improve the incorporation and delivery of this compound to hair follicles, thereby increasing its dermal bioavailability. researchgate.netnih.govacs.orgnih.gov In vivo studies in rats have demonstrated the successful penetration of these this compound-loaded vaterite carriers into hair follicles. nih.gov Evaluation in a guinea pig model of trichophytosis showed that the vaterite-based this compound formulation provided a more rapid and effective therapeutic outcome compared to free this compound or isoconazole, requiring fewer treatment procedures. acs.orgnih.gov Research also indicates that ultrasound can assist the delivery of these carriers, with studies showing no significant cytotoxicity to fibroblasts in vitro or dermal toxicity in healthy rabbits in vivo. acs.orgnih.gov

Sustained Release Formulations for Specific Applications

Sustained release formulations are designed to deliver a drug over an extended period, maintaining therapeutic concentrations and potentially improving treatment adherence and efficacy, particularly for chronic conditions or those requiring localized, long-term drug presence.

Poly(lactic-co-glycolide) (PLGA) Microparticles

Poly(lactic-co-glycolide) (PLGA) is a widely used biodegradable polymer matrix for creating sustained-release drug delivery systems. researchgate.netnih.gov PLGA microparticles have been investigated for their potential to provide prolonged release of this compound, particularly in applications requiring sustained local drug levels.

A notable application area is the use of this compound-loaded PLGA microparticles for the treatment of ocular neovascularization, a key pathological feature of wet age-related macular degeneration (AMD). researchgate.netnih.govprf.orgarvojournals.orgpurdue.eduarvojournals.org Given that current AMD treatments often involve frequent intravitreal injections, a sustained-release formulation of this compound, which has shown antiangiogenic properties, could offer a significant advantage. prf.orgarvojournals.org

Studies have focused on developing this compound-loaded PLGA microparticles suitable for intravitreal injection. researchgate.netnih.govarvojournals.org The incorporation of additives such as magnesium hydroxide has been explored to modulate the drug release kinetics from the PLGA matrix. researchgate.netnih.govpurdue.eduarvojournals.org In vitro studies have demonstrated that these formulations can achieve sustained release of this compound for over 30 days. researchgate.netnih.govpurdue.eduarvojournals.org In vivo evaluation in a murine model of laser-induced choroidal neovascularization (CNV) showed that intravitreally injected this compound-loaded PLGA microparticles effectively reduced CNV lesion volume for at least 6 weeks, a sustained effect not observed with free this compound. researchgate.netnih.govarvojournals.orgpurdue.edu These findings suggest that PLGA microparticles can provide a prolonged antiangiogenic effect, positioning this formulation as a potential long-acting therapeutic option for ocular neovascularization. nih.govarvojournals.orgpurdue.edu

The in vitro release profiles of this compound from PLGA microparticles can be influenced by the composition of the formulation, as illustrated by data showing the effect of varying magnesium hydroxide content:

Mg(OH)₂ Content (% w/w)Approximate Release at 1 Day (%)Approximate Release at 5 Days (%)Approximate Release Duration
2~18>75~38 days (100% release)
5->75-
10->90-
20~70Complete release5 days

This data indicates that formulations with lower magnesium hydroxide content, such as 2% w/w, exhibit a reduced initial burst release and provide a more extended release of this compound. purdue.eduarvojournals.org

Toxicological and Safety Research

Mechanisms of Adverse Effects

Griseofulvin's toxic effects are linked to its interactions with cellular processes, particularly those involving microtubules and hepatic function.

Association with Liver Injury and Mallory Body Formation

This compound has been associated with liver injury and the formation of Mallory bodies (MBs) in hepatocytes frontiersin.orgmdpi.comresearchgate.nettandfonline.commdpi.com. Mallory bodies are aggregates primarily composed of intermediate filament proteins, such as keratins 8 and 18 (K8/K18) mdpi.comresearchgate.netnih.gov. Studies, particularly in rodents, have shown that this compound treatment induces the formation of these bodies mdpi.comresearchgate.nettandfonline.comnih.gov.

The mechanism involves this compound and its metabolites, including 6-desmethylthis compound (6-DMG) and 4-desmethylthis compound (4-DMG), interacting favorably with cytokeratin intermediate filament proteins K8 and K18 mdpi.comnih.gov. This binding can alter keratin solubility and phosphorylation on specific sites, leading to protein misfolding and the formation of aggregates mdpi.comresearchgate.net. Research using molecular docking analysis has indicated that this compound metabolites have stronger interactions with K8 and K18 than the parent compound mdpi.comnih.gov. This disruption of the keratin cytoskeleton is believed to contribute to liver injury mdpi.comresearchgate.net.

In mice, a this compound-containing diet has been shown to induce Mallory body formation, potentially linked to the overexpression of the Krt8 gene and the binding of this compound to K8 and K18 in hepatocytes mdpi.comresearchgate.net. These interactions change keratin solubility and phosphorylation, causing protein misfolding mdpi.comresearchgate.net. While Mallory bodies are characteristic of alcoholic hepatitis in humans, they can be induced in mice by chronic this compound intoxication, providing a model for studying the molecular mechanisms of keratin's role in response to chemical injuries researchgate.netnih.gov. Studies in mice have shown that this compound intoxication leads to changes in keratin solubility and increased phosphorylation of specific keratin sites (K8 pS79, K8 pS436, and K18 pS33), particularly in insoluble protein fractions researchgate.net.

Disturbance of Porphyrin Metabolism

This compound is known to disturb porphyrin metabolism frontiersin.orgupenn.edunih.govscilit.com. This disturbance is characterized by the accumulation of porphyrins, particularly protoporphyrin, in the liver and, in some cases, in circulating red blood cells upenn.edu. Early experiments in mice demonstrated that oral administration of this compound led to a marked disturbance of porphyrin metabolism within 24 hours, primarily causing massive fecal excretion of protoporphyrin and liver accumulation of protoporphyrin upenn.edu. This indicated a hepatic type of porphyria upenn.edu. After several days of treatment in mice, a significant increase in protoporphyrin was also observed in peripheral red blood cells, suggesting a mixed hepatic-erythropoietic distribution upenn.edu.

The porphyrinogenic effect in mice may result from the inhibition of ferrochelatase and a compensatory induction of δ-aminolevulinic acid synthase (ALA synthase) nih.gov. A green pigment that inhibited ferrochelatase was isolated from the livers of this compound-treated mice, with chromatographic characteristics identical to N-methyl protoporphyrin iarc.fr. This compound-induced accumulation of porphyrins in mouse liver has been followed by cell damage, necrotic, and inflammatory processes nih.goviarc.fr. While this compound therapy can disturb porphyrin metabolism in humans, the effect is considered moderate compared to the mouse model nih.goviarc.fr.

Interference with Chromosomal Distribution and Aneuploidy

This compound is recognized for its ability to interfere with chromosomal distribution and induce aneuploidy iarc.froup.comresearchgate.netoup.com. This effect is primarily attributed to its interaction with microtubules, which are essential components of the mitotic spindle responsible for chromosome segregation during cell division mdpi.comiarc.fr. This compound acts as a spindle poison, disrupting the formation and function of spindle microtubules nih.gov.

Studies have shown that this compound can induce micronuclei containing whole chromosomes (kinetochore-positive) in isolated human lymphocytes, indicating aneuploidic events iarc.fr. It has also been observed to alter the cell cycle of lymphocytes, increasing the percentage of triploid cells iarc.fr. In mice, this compound has been shown to induce aneuploidy and polyploidy in germ cells, particularly oocytes, in a time- and dose-dependent manner oup.comresearchgate.netoup.com. It can cause mitotic arrest of oocytes in metaphase I at high doses, and while these cells may overcome the block, they often form polyploid zygotes iarc.fr. Even at lower doses, the frequency of hyperploid cells can be substantially increased iarc.fr.

Research in orally treated mice has provided evidence that this compound induces both cell cycle delay and aneuploidy in bone marrow cells oup.comresearchgate.net. A statistically significant increase in the average generation time in bone marrow cells of mice treated with 666 and 2000 mg/kg this compound suggested interference with cell cycle progression researchgate.net. Frequencies of hyperploid cells were significantly higher in treated groups compared to controls, although the effect was not always dose-dependent within the tested range oup.comresearchgate.net.

The mechanism involves this compound binding to tubulin, interfering with the normal polymerization of microtubule protein iarc.fr. This colchicine-like effect can disturb the correct distribution of chromosomes during cell division iarc.fr.

Immunological Basis of Severe Cutaneous Adverse Reactions (SCARs)

Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), are rare but potentially life-threatening reactions associated with various drugs, including this compound npra.gov.mynih.govnih.govjmust.org. While the pathophysiology of how drugs induce SCARs is not fully understood, these reactions are generally considered delayed type IV hypersensitivity reactions triggered by a T-cell-mediated drug-specific immune response npra.gov.mynih.gov.

The clinical heterogeneity of SCARs may be attributed to the activation of different effector or regulatory cells that produce specific cytokines npra.gov.my. This compound-induced SCARs, such as SJS, TEN, and AGEP, have been reported npra.gov.myrjptonline.org. The time-to-onset of symptoms following this compound use has been reported to range from days to weeks npra.gov.my. Recovery is typically documented after discontinuing this compound and providing supportive treatment npra.gov.my.

Differential Toxicity Profiles Across Species (e.g., Rodents vs. Humans)

Studies have indicated differential toxicity profiles of this compound across species, particularly between rodents and humans frontiersin.orgmdpi.commdpi.com. While this compound has been used in humans for many years with a generally low incidence of severe toxicity, animal studies, especially in rodents, have shown clear evidence of various acute and chronic toxic effects, including liver and thyroid cancer frontiersin.orgnih.gov.

The severity of hepatitis and Mallory body formation appears to differ between rodents and humans mdpi.commdpi.com. Research suggests that the stronger binding affinity of this compound to Keratin 18 (K18) in rodents compared to humans may explain the observed difference in the severity of hepatitis mdpi.commdpi.comnih.gov. Molecular docking analysis showed lower binding energy (indicating stronger binding) to K18 in rat and mouse compared to human nih.gov.

In animal experiments, while high doses of this compound caused toxic reactions, mainly porphyrin metabolism disorder and carcinogenicity in mice, no pathological changes were observed in other experimental animals like guinea pigs, rats, rabbits, cats, and dogs at very high doses corresponding to body weight frontiersin.org. Despite the findings in animal models, severe poisoning or tumor changes have not been widely reported in clinical use in humans since 1973 frontiersin.org. However, the lack of extensive human research data means that human risks cannot be completely ruled out, and more clinical trials are needed to systematically evaluate its toxicity in humans frontiersin.org.

Genotoxicity and Carcinogenicity Studies

This compound has been evaluated for its genotoxic and carcinogenic potential in various studies iarc.froup.comoup.com. It is considered genotoxic due to its ability to induce micronuclei and aneuploidy in rodent cells in vitro and in vivo, as well as in human cells in vitro iarc.fr.

Studies have shown that this compound can induce sister chromatid exchange in bone-marrow cells and chromosomal aberrations in spermatocytes of mice treated in vivo iarc.frresearchgate.net. However, it did not induce micronucleus formation in the bone-marrow cells of mice treated in vivo in some studies iarc.fr. This compound has also been reported to induce abnormal sperm morphology in certain mouse strains iarc.fr. While it did not induce gene mutations in bacteria or cultured mammalian cells, it induced DNA damage, somatic mutation, and mitotic recombination in Drosophila melanogaster iarc.fr.

Regarding carcinogenicity, animal studies provide evidence that this compound can cause liver and thyroid cancer in rodents frontiersin.orgnih.gov. Early studies reported that this compound could induce liver cancer in young mice frontiersin.org. Another study found that mice developed nodular hyperplasia and liver cancer after 12-14 months of this compound administration frontiersin.org. Dietary exposure to this compound for 5 weeks led to a significant occurrence of hepatocellular tumors in mice and thyroid tumors in rats, but no carcinogenic activity was observed in hamsters frontiersin.org. Chronic liver damage associated with porphyria, Mallory body formation, enhanced cell proliferation, liver enlargement, and enzyme induction are considered potential contributors to the hepatocarcinogenic effect observed in mice tandfonline.comnih.goviarc.fr.

In humans, the evidence for carcinogenicity is considered inadequate oup.com. Although an excess of thyroid cancer was reported among this compound users in a 9-year follow-up study, this association was not observed in a 15-year follow-up for cancer at any site iarc.froup.com. This compound, along with other drugs, has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC) based on inadequate evidence in humans and sufficient evidence in experimental animals oup.com.

Summary of Genotoxicity and Carcinogenicity Findings:

Test SystemEndpointResult (In vitro/In vivo)SpeciesReference
Human lymphocytesMicronucleus formation (aneuploidy)Positive (In vitro)Human iarc.fr
Human lymphocytesCell cycle alteration (triploidy)Positive (In vitro)Human iarc.fr
Mouse bone marrow cellsSister chromatid exchangePositive (In vivo)Mouse iarc.frresearchgate.net
Mouse spermatocytesChromosomal aberrationsPositive (In vivo)Mouse iarc.fr
Mouse bone marrow cellsMicronucleus formationNegative (In vivo)Mouse iarc.fr
Mouse germ cells (oocytes)Aneuploidy, Polyploidy, Meiotic arrestPositive (In vivo)Mouse iarc.froup.comresearchgate.netoup.com
Mouse bone marrow cellsAneuploidy, Mitotic delayPositive (In vivo)Mouse oup.comresearchgate.net
Drosophila melanogasterDNA damage, Somatic mutation, Mitotic recombinationPositiveDrosophila iarc.fr
Bacteria (Salmonella typhimurium, Escherichia coli, Bacillus subtilis)Gene mutation, SOS repair, rec testNegativeBacteria iarc.fr
Cultured mammalian cellsGene mutationNegativeMammalian iarc.fr
MouseLiver cancer, Nodular hyperplasiaPositive (In vivo)Mouse frontiersin.org
RatThyroid tumorsPositive (In vivo)Rat frontiersin.org
HamsterCarcinogenicityNegative (In vivo)Hamster frontiersin.org

Teratogenicity and Embryotoxicity Research

Research into the teratogenic and embryotoxic potential of this compound has been conducted in various animal species, with some limited data available from human observations. Animal studies have provided clear evidence of adverse developmental effects.

In rats, oral administration of this compound at doses of 125, 250, 750, 1250, or 1500 mg/kg body weight per day during days 6–15 of gestation resulted in malformations in the offspring of dams receiving doses ≥ 250 mg/kg body weight per day. Observed malformations included tail anomalies, anophthalmia, anal atresia, and exencephaly. Decreased survival rates were also noted at these doses. iarc.fr Similar observations were made in rats given oral doses of 50 or 500 mg/kg body weight per day on days 11–14 of gestation. iarc.fr Administration of micronized this compound dissolved in polyethylene glycol 300 to rats at doses of 50, 250, or 500 mg/kg body weight per day on days 6–15 of gestation led to a dose-related reduction in pup birth weight and the number of live pups, alongside an increased incidence of resorptions. Severe vertebral and rib malformations were reported at the two higher doses. iarc.fr Reports from Soviet literature also indicate that a this compound preparation was found to be embryotoxic and teratogenic upon oral administration to pregnant Wistar rats. rwandafda.gov.rwfda.gov

Teratogenicity has also been described in cats at doses of 100 mg per day or less, causing a variety of defects in the central nervous system, the eye, and soft tissue. iarc.frrwandafda.gov.rw Pups with abnormalities have been reported in the litters of a few bitches treated with this compound. rwandafda.gov.rwfda.govfda.gov

In mice, high doses of this compound (200–2000 mg/kg body weight) administered simultaneously with human chorionic gonadotropin to induce ovulation caused mitotic arrest of the oocytes in metaphase I. iarc.fr A study in Drosophila melanogaster also demonstrated a teratogenic effect, manifested as a reduction of ommatidia, phenocopying the mutation ey (eyeless-4:2.0). A relationship was observed between the level of phenocopies and the dose of this compound, the genotypes of treated larvae, the interval and duration of exposure, and sexual differences. researchgate.net

This compound has also been shown to induce chromosomal aberrations in animal spermatocytes. rwandafda.gov.rwdrugs.commedicines.org.uk Suppression of spermatogenesis has been reported in rats, although this has not been confirmed in humans. rwandafda.gov.rwfda.govfda.govsimsrc.edu.in

The mechanism underlying this compound's reproductive toxicity and induction of numerical chromosome aberrations may be related to its action as a spindle poison, disturbing microtubule formation. nih.govtandfonline.com

Based on the available data, particularly the findings from animal studies and case reports in humans, this compound is considered to have the potential for adverse effects on the human fetus. rwandafda.gov.rwfda.gov

Here is a summary of selected animal teratogenicity/embryotoxicity findings:

SpeciesDose (Route)Gestation DaysObserved EffectsSource
Rat≥ 250 mg/kg bw/day (Oral)6-15Malformations (tail anomalies, anophthalmia, anal atresia, exencephaly), decreased survival iarc.fr
Rat50 or 500 mg/kg bw/day (Oral)11-14Similar malformations iarc.fr
Rat250 or 500 mg/kg bw/day (Micronized, likely oral)6-15Reduced pup birth weight, decreased live pups, increased resorptions, severe vertebral and rib malformations iarc.fr
RatOral administration (preparation not specified)Pregnant Wistar ratsEmbryotoxic and teratogenic effects rwandafda.gov.rwfda.gov
Cat≤ 100 mg/dayNot specifiedDefects in CNS, eye, soft tissue iarc.frrwandafda.gov.rw
DogNot specifiedNot specifiedPups with abnormalities rwandafda.gov.rwfda.govfda.gov
Mouse200-2000 mg/kg bw (with hCG)Not specifiedMitotic arrest of oocytes in metaphase I iarc.fr
Drosophila melanogasterVarious concentrationsLarval developmentReduction of ommatidia (teratogenic effect) researchgate.net

Future Research Directions and Emerging Applications

Further Elucidation of Molecular Targets Beyond Tubulin

While griseofulvin is known to interfere with microtubule function by binding to tubulin, particularly affecting mitosis in fungal and mammalian cells, research suggests its effects may extend to other cellular targets. Studies indicate that at clinically relevant concentrations in mammalian cells, the primary target might not be tubulin itself, but rather a microtubule-associated protein dtu.dk. This compound has been shown to disrupt microtubule polymerization and organization in various cell lines, including HeLa cells pnas.orgnih.gov. It has also been reported to bind to both alpha- and beta-tubulin in the mammalian brain nih.gov. Evidence from molecular dynamics simulations suggests gamma-tubulin as a possible target nih.gov. Furthermore, some reports propose that this compound's effect on microtubule polymerization in mammals could be due to the disruption of microtubule-associated protein (MAP) function rather than a direct effect on alpha, beta, or gamma tubulins, as higher concentrations were needed to inhibit polymerization in MAP-free microtubules nih.gov. Recent research also indicates a binding potential of this compound with keratin cytoskeleton intermediate filament proteins K8 and K18, potentially altering keratin solubility and leading to the formation of Mallory bodies in hepatocytes mdpi.comnih.gov. A more detailed understanding of these cellular targets and the underlying binding interactions holds promise for increasing the therapeutic applications of this compound and its derivatives dtu.dk.

Development of this compound Derivatives with Improved Properties

The development of this compound derivatives is a significant area of research aimed at overcoming some of the limitations of the parent compound, such as poor solubility and modest metabolic stability. Numerous analogs have been synthesized with the goal of improving its properties dtu.dkbohrium.comacs.org.

Enhanced Solubility and Metabolic Stability

This compound is classified as a Class II drug according to the Biopharmaceutics Classification System (BCS), indicating low solubility and high permeability acs.org. Its poor water solubility limits its absorption and bioavailability, hindering in vivo research and reducing its druggability frontiersin.org. Strategies to improve solubility and metabolic stability include structural modifications such as the conversion of aryl methyl ethers into aryl difluoromethyl ethers and the conversion of the C-ring ketone into polar oximes nih.govresearchgate.netdtu.dk. The formation of polar oximes appears to be a promising strategy for improving the properties of this compound analogues nih.govresearchgate.net. Studies have shown that certain derivatives, such as the 2'-benzylamine analogue, exhibit significantly increased solubility and improved metabolic stability compared to this compound and its more potent anticancer analogue, 2'-benzyloxy this compound researchgate.net. Complexation with cyclodextrin derivatives, particularly HP-γ-cyclodextrin, has also demonstrated a substantial increase in this compound's water solubility, with one study reporting a 477-fold increase mdpi.com. This complexation also led to improved pharmacokinetic properties in vivo, including increased Cmax and AUC, and a longer half-life mdpi.com.

Here is a table summarizing data on the improved solubility and metabolic stability of some this compound analogues:

CompoundModification StrategySolubility Improvement (vs. This compound or Analogue 2)Metabolic Stability ImprovementReference
Polar oxime derivativesConversion of C-ring ketone to oximesImprovedImproved nih.govresearchgate.net
2'-benzylamine analogue (10)Modification at 2' position200-fold increase (vs. compound 2)Improved researchgate.net
This compound-HP-γ-cyclodextrin ComplexComplexation with HP-γ-cyclodextrin477-fold increase (vs. This compound)Improved pharmacokinetic profile mdpi.com

Increased Potency and Selectivity for Specific Targets

Structural modifications of this compound have also aimed at increasing its potency and selectivity for specific targets, particularly in the context of cancer therapy. Studies have prepared new this compound derivatives with good antitumor activity through structural modification frontiersin.org. For instance, the 2'-demethoxy-2'-propoxy analog was found to be more potent in Chinese hamster V79 cells, suggesting that the anticancer effect could be enhanced through structural modification dtu.dk. Experimental studies have reported that this compound analogues with a sulfonyl group in the 2' or 3' position showed significant activity against oral squamous carcinoma and a triple-negative breast cancer cell line resistant to microtubule inhibitors mdpi.com. Modifications at the 2'-benzyloxy position have also remarkably enhanced anticancer activity compared to the parent compound mdpi.com. Computational studies exploring interactions with different human beta-tubulin isotypes suggest that certain derivatives may have favorable interactions and significant affinity, potentially offering a strategy for targeting drug-resistant cancer cells nih.govmdpi.com.

Repurposing in Emerging Disease Areas

The potential of repurposing this compound for conditions other than fungal infections is an active area of research, driven by its observed biological properties beyond antifungal activity.

Continued Investigation in Cancer Therapy

This compound has garnered significant attention for its potential as an anticancer agent, owing to its ability to inhibit cell proliferation, induce apoptosis, and affect microtubule function in cancer cells nih.govfrontiersin.orgnih.gov. It has shown inhibitory effects on cancer cell division and may induce cell death through interaction with the mitotic spindle microtubule nih.gov. This compound can inhibit the proliferation, migration, and invasion of tumor cells, induce apoptosis, and inhibit tumor growth frontiersin.org. Studies have demonstrated its significant antitumor activity against various cancers, including cervical cancer, breast cancer, non-small-cell lung cancer, colorectal cancer, and adrenocortical cancer frontiersin.org. Its mechanisms of action in cancer cells include interfering with the cell cycle, inducing apoptosis, regulating signaling pathways like Wnt/β-catenin, NF-κB, and cGAS-STING, and affecting the expression of proteins such as p53, Bcl-2, Bax, and cytochrome C frontiersin.org. This compound has also been shown to inhibit centrosomal clustering, a strategy used by many cancer cells to avoid lethal multipolar cell divisions dtu.dksciencedaily.com. The combination of this compound with other therapies, such as radiotherapy or certain chemotherapy drugs like vincristine or nocodazole, has shown synergistic effects in enhancing therapeutic outcomes in cancer models frontiersin.orgnih.govresearchgate.net. Future research in this area includes developing this compound composites or GF-loaded nanomaterials to improve bioavailability for cancer treatment frontiersin.org.

Exploration in Viral Infections (e.g., SARS-CoV-2)

Beyond its antifungal use, this compound has shown antiviral properties, notably inhibiting the replication of the hepatitis C virus (HCV) by interfering with microtubule polymerization frontiersin.orgnih.govtandfonline.comresearchgate.net. More recently, the potential of repurposing this compound for the treatment of SARS-CoV-2 infection has been explored, primarily through computational studies mdpi.comnih.govresearchgate.netnih.govresearchgate.netijnrd.orgmdpi.com. Molecular docking analyses have revealed that this compound and its derivatives have good binding potential with key SARS-CoV-2 targets, including the main protease, RNA-dependent RNA polymerase (RdRp), and the spike protein receptor-binding domain (RBD), suggesting potential inhibitory effects on viral entry and replication mdpi.comnih.govresearchgate.netnih.govresearchgate.netmdpi.com. Furthermore, this compound may enhance ACE2 function, which could contribute to relieving COVID-19 symptoms mdpi.comnih.govresearchgate.net. These findings suggest that this compound and its derivatives may be considered when designing future therapeutic options for SARS-CoV-2 infection researchgate.netnih.govresearchgate.net.

Here is a table summarizing some potential applications of this compound and its derivatives in emerging disease areas:

Disease AreaObserved Effect/Potential MechanismReference
CancerInhibition of cell proliferation, induction of apoptosis, interference with cell cycle and microtubule function, inhibition of centrosomal clustering. nih.govfrontiersin.orgdtu.dknih.govsciencedaily.com
Hepatitis C VirusInhibition of viral replication by interfering with microtubule polymerization. frontiersin.orgnih.govtandfonline.comresearchgate.net
SARS-CoV-2Potential inhibition of viral entry and replication through binding to key viral proteins (main protease, RdRp, RBD) and human ACE2. mdpi.comnih.govresearchgate.netnih.govresearchgate.netmdpi.com

Advanced Preclinical and Clinical Study Designs

Future research into this compound (PubChem CID: 3485) is increasingly focusing on advanced preclinical and clinical study designs to fully explore its potential beyond its traditional antifungal uses, particularly in areas like oncology and novel delivery methods. These advanced designs aim to address limitations such as low bioavailability and to investigate new therapeutic applications with greater efficiency and precision.

In preclinical research, the emphasis is shifting towards more predictive and human-relevant models. While traditional 2D cell cultures are cost-effective, they often lack the biological complexity to accurately predict human responses emulatebio.com. Advanced preclinical studies are incorporating complex in vitro models (CIVMs), such as 3D cell cultures, spheroids, organoids, and dynamic microphysiological systems (MPS) like Organ-Chips emulatebio.com. These models better simulate the structure and function of human tissues and organs, providing a more physiologically relevant environment for studying drug effects and improving the predictability of preclinical data for IND submissions emulatebio.com. For instance, disease-specific Organ-Chip models can be used to test drug candidates in a human-relevant disease context emulatebio.com.

In vivo preclinical studies are also evolving, with a focus on selecting animal models that are more relevant to human diseases to improve the translatability of findings virscio.comtranscurebioservices.com. This is particularly crucial for evaluating potential new applications like this compound's antitumor effects, which have been explored in models such as COLO-205 thymus-less mice for colorectal cancer studies frontiersin.org. Advanced preclinical designs may involve combination therapy studies, as seen in research combining this compound with other agents like vinblastine, which showed synergistic effects against MCF-7 breast cancer cells in preclinical settings researchgate.net.

Furthermore, preclinical studies are utilizing advanced formulations of this compound to improve its properties. Research into this compound-loaded nanoparticles, microparticles, and invasomal gels highlights the use of specific study designs to evaluate characteristics like particle size, encapsulation efficiency, zeta potential, and in vitro release kinetics frontiersin.orgresearchgate.netijpsjournal.com. Studies assessing skin penetration and retention of topical formulations on models like porcine skin are examples of detailed preclinical evaluations for novel delivery systems researchgate.net.

In clinical trial design, there is a growing adoption of innovative approaches beyond traditional fixed-sample size, parallel-group randomized controlled trials (RCTs) nih.govwho.int. Adaptive designs, which allow for prospective modifications based on accumulating data, are gaining prominence for their potential to increase flexibility, efficiency, and speed in drug development nih.govefpia.eu. These can include adaptations to dose selection (e.g., adaptive dose-finding designs in early phases), sample size adjustments, and treatment arm selection (e.g., drop-the-losers designs) nih.govefpia.eu. Seamless designs, which combine objectives of different trial phases into a single study, can also reduce the time between phases nih.govefpia.eu.

Master protocols, such as platform, basket, and umbrella trials, represent another advanced clinical trial design being utilized who.intefpia.eu. These overarching protocols allow for the simultaneous evaluation of multiple interventions, potentially for a single disease with different subtypes or multiple closely related diseases who.intefpia.eu. While not specifically detailed for this compound in the provided search results, the principles of these designs could be applied to investigate this compound's effects in different patient populations or in combination with various agents for emerging indications like cancer.

The integration of advanced statistical methodologies, including Bayesian approaches, is also a key aspect of modern clinical trial design, enabling more informed decision-making based on accumulating data nih.gov.

Detailed research findings from advanced preclinical studies on novel this compound formulations illustrate the type of data generated. For example, a study on this compound-loaded invasomal gel formulations evaluated drug release over time ijpsjournal.com.

FormulationCumulative Drug Release at 6 hours (%)Cumulative Drug Release at 10 hours (%)Cumulative Drug Release at 12 hours (%)
IG-198.12--
IG-2-94.65-
IG-374.65--
F3 (Invasomal)--Sustained release

Another preclinical study on this compound-loaded lipid nanoparticles (GF-LN) investigated in vitro skin penetration and retention on porcine skin researchgate.net.

FormulationPenetration Flux (μg/cm²/hr)Retention in Epidermis (μg/cm²)Retention in Dermis (μg/cm²)
GF-LN0.067 ± 0.00314.9 ± 0.483~3.7 (estimated from "four-folds higher in the epidermis")

These examples demonstrate how advanced preclinical study designs provide detailed data on the performance of novel this compound formulations, which is crucial for guiding future clinical development.

The application of advanced preclinical and clinical study designs to this compound research is essential for overcoming existing challenges, such as improving its bioavailability and exploring its full therapeutic potential, particularly in non-fungal applications like oncology.

Q & A

Q. What are the key challenges in optimizing Griseofulvin synthesis for scalable production, and what methodological approaches address them?

this compound synthesis involves a nonreducing polyketide synthase (gsfA) to form the heptaketide backbone, followed by methylation via O-methyltransferases (gsfB/gsfC) . Challenges include low yields in benzophenone intermediate formation and regioselective methylation. Methodological improvements include:

  • Enzyme engineering : Modifying gsfA/gfsB activity to enhance catalytic efficiency .
  • Chemoenzymatic routes : Combining microbial synthesis with chemical steps (e.g., alcoholysis of griseofulvic acid) to improve scalability .
  • Crystallographic analysis : Using X-ray diffraction (space group P41, Z=4) to guide stereochemical control .

Q. How does this compound’s poor aqueous solubility impact preclinical studies, and what formulation strategies mitigate this limitation?

this compound’s solubility in aqueous buffers is ≤8.63·10⁻⁷ mol/L, necessitating advanced formulation techniques :

  • Ultramicrosizing : Reduces particle size to 1–2 µm, achieving bioequivalence with lower doses .
  • Solid dispersions : Incorporation into PEG matrices increases dissolution rates by 3–5× via fusion/solvent methods .
  • Liposomal encapsulation : Enhances GI absorption (2.6× higher Cmax vs. suspensions) . Methodological validation includes FT-IR spectroscopy and DSC to confirm amorphous state stability .

Q. What experimental models are used to study this compound’s antifungal mechanism, and how do they reconcile conflicting data on microtubule disruption vs. nucleic acid synthesis inhibition?

this compound’s fungistatic action involves microtubule binding (α/β-tubulin) and mitotic arrest . Contradictions arise from species-specific effects:

  • In vitro fungal models : Microsporum spp. show microtubule depolymerization, while Trichophyton spp. exhibit RNA synthesis inhibition .
  • Yeast assays : S. cerevisiae studies reveal SGS1 gene repression, linking mitotic disruption to genomic instability .
  • Human cell lines : HeLa cells demonstrate metaphase arrest via suppression of microtubule dynamic instability (IC50 = 20 µM) .

Advanced Research Questions

Q. How can researchers resolve contradictory structure-activity relationship (SAR) data for this compound analogs targeting cancer cells?

Disparate SAR data arise from divergent assays (e.g., fungal vs. mammalian microtubule affinity) . Methodological solutions include:

  • 2D NMR/X-ray crystallography : Confirm stereochemical assignments (e.g., 4/6-methoxy positional isomers) .
  • Phenotypic screening : Centrosomal clustering inhibition (IC50 = 5 µM) identifies analogs with dual antifungal/anticancer activity .
  • Dynamic instability assays : Quantify microtubule rescue/frequency rates to differentiate mechanisms from vinca alkaloids .

Q. What experimental designs are critical for evaluating this compound’s ecological toxicity in agricultural or environmental contexts?

Ecotoxicity studies require multispecies assays:

  • Soil microbiota : 16S rRNA sequencing reveals bacterial dominance shifts (bacteria > actinomycetes > fungi) at 1,000 mg/kg .
  • Enzyme inhibition : Dose-dependent urease suppression (IC50 = 200 mg/L) and dehydrogenase biphasic effects .
  • Plant models : Arabidopsis root elongation assays show minimal phytotoxicity below 200 mg/L .

Q. How does this compound’s pharmacokinetic profile influence its repurposing for oncology, and what combination therapies are methodologically viable?

this compound’s low oral bioavailability (27–72.5%) and hepatic metabolism to 6-DMG limit monotherapy efficacy . Strategies include:

  • Adjuvant combinations : Synergy with taxanes (e.g., paclitaxel) via complementary microtubule stabilization/destabilization .
  • Nanocarrier systems : PEGylated liposomes improve tumor targeting and reduce hepatic first-pass metabolism .
  • Metabolite profiling : LC-MS/MS quantifies 6-DMG levels to optimize dosing schedules .

Q. What advanced techniques elucidate this compound’s species-specific efficacy against dermatophytes (e.g., Microsporum vs. Trichophyton)?

Mechanistic divergence is probed via:

  • Proteomic profiling : Tubulin isoform expression differences in Microsporum (β-tubulin dominance) vs. Trichophyton (α-tubulin mutations) .
  • Sweat simulation assays : Stratum corneum "wick effect" enhances drug transfer in Microsporum-infected models .
  • Comparative genomics : Trichophyton CYP450 upregulation correlates with this compound resistance .

Methodological Notes

  • Data validation : Cross-reference IR spectra (2000–700 cm⁻¹) and 60 MHz ¹H NMR to confirm analog identity .
  • Ethical compliance : Adhere to ECHA guidelines for ecotoxicity data reproduction .
  • Clinical relevance : Prioritize in vivo PK/PD models over static in vitro MIC assays .

Retrosynthesis Analysis

AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.

One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.

Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.

Strategy Settings

Precursor scoring Relevance Heuristic
Min. plausibility 0.01
Model Template_relevance
Template Set Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis
Top-N result to add to graph 6

Feasible Synthetic Routes

Reactant of Route 1
Reactant of Route 1
Griseofulvin
Reactant of Route 2
Reactant of Route 2
Griseofulvin

Disclaimer and Information on In-Vitro Research Products

Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.